WO2023052995A1 - Compositions with high urea content and methods for boosting actives - Google Patents
Compositions with high urea content and methods for boosting actives Download PDFInfo
- Publication number
- WO2023052995A1 WO2023052995A1 PCT/IB2022/059185 IB2022059185W WO2023052995A1 WO 2023052995 A1 WO2023052995 A1 WO 2023052995A1 IB 2022059185 W IB2022059185 W IB 2022059185W WO 2023052995 A1 WO2023052995 A1 WO 2023052995A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- skin conditioning
- skin
- conditioning composition
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 415
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims abstract description 137
- 239000004202 carbamide Substances 0.000 title claims abstract description 69
- 238000000034 method Methods 0.000 title claims abstract description 32
- 230000003750 conditioning effect Effects 0.000 claims abstract description 209
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 78
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims abstract description 66
- 150000001413 amino acids Chemical class 0.000 claims abstract description 45
- 230000000295 complement effect Effects 0.000 claims abstract description 39
- 229960002622 triacetin Drugs 0.000 claims abstract description 33
- 239000001087 glyceryl triacetate Substances 0.000 claims abstract description 32
- 235000013773 glyceryl triacetate Nutrition 0.000 claims abstract description 32
- 239000007853 buffer solution Substances 0.000 claims abstract description 30
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000001069 triethyl citrate Substances 0.000 claims abstract description 28
- 235000013769 triethyl citrate Nutrition 0.000 claims abstract description 28
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000004615 ingredient Substances 0.000 claims abstract description 22
- 150000001261 hydroxy acids Chemical class 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 52
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 45
- 235000001014 amino acid Nutrition 0.000 claims description 43
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 39
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 38
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 31
- 239000004471 Glycine Substances 0.000 claims description 26
- 239000003755 preservative agent Substances 0.000 claims description 25
- 235000014655 lactic acid Nutrition 0.000 claims description 19
- 239000004094 surface-active agent Substances 0.000 claims description 19
- 239000004310 lactic acid Substances 0.000 claims description 18
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 17
- 235000011187 glycerol Nutrition 0.000 claims description 15
- 239000002562 thickening agent Substances 0.000 claims description 15
- 235000015165 citric acid Nutrition 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 12
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 11
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 11
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 10
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 10
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 238000002425 crystallisation Methods 0.000 claims description 10
- 230000008025 crystallization Effects 0.000 claims description 10
- 230000002335 preservative effect Effects 0.000 claims description 10
- 239000001540 sodium lactate Substances 0.000 claims description 10
- 235000011088 sodium lactate Nutrition 0.000 claims description 10
- 229940005581 sodium lactate Drugs 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 9
- 239000003906 humectant Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 230000006641 stabilisation Effects 0.000 claims description 8
- 238000011105 stabilization Methods 0.000 claims description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 7
- 235000018417 cysteine Nutrition 0.000 claims description 7
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- 230000002459 sustained effect Effects 0.000 claims description 7
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 6
- 235000011083 sodium citrates Nutrition 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 238000005096 rolling process Methods 0.000 claims description 4
- 210000003491 skin Anatomy 0.000 description 220
- 239000003921 oil Substances 0.000 description 80
- 235000019198 oils Nutrition 0.000 description 80
- 229940024606 amino acid Drugs 0.000 description 32
- -1 for example Chemical compound 0.000 description 32
- 238000011282 treatment Methods 0.000 description 25
- 239000000126 substance Substances 0.000 description 24
- 229930195733 hydrocarbon Natural products 0.000 description 21
- 150000002430 hydrocarbons Chemical class 0.000 description 21
- 239000004215 Carbon black (E152) Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- 125000004432 carbon atom Chemical group C* 0.000 description 16
- 150000001277 beta hydroxy acids Chemical class 0.000 description 15
- 229960000448 lactic acid Drugs 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 12
- 210000000434 stratum corneum Anatomy 0.000 description 12
- 239000000872 buffer Substances 0.000 description 11
- 206010040844 Skin exfoliation Diseases 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- 229940031575 hydroxyethyl urea Drugs 0.000 description 10
- 229920002545 silicone oil Polymers 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- 230000003716 rejuvenation Effects 0.000 description 9
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 8
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 description 8
- 229940061720 alpha hydroxy acid Drugs 0.000 description 8
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- 229940106025 phenylethyl resorcinol Drugs 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 229920001285 xanthan gum Polymers 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 125000001153 fluoro group Chemical group F* 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 5
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229960004106 citric acid Drugs 0.000 description 5
- 239000003974 emollient agent Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 150000002191 fatty alcohols Chemical class 0.000 description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 5
- 229960005323 phenoxyethanol Drugs 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- 235000002906 tartaric acid Nutrition 0.000 description 5
- 239000011975 tartaric acid Substances 0.000 description 5
- 229960001367 tartaric acid Drugs 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 4
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000035618 desquamation Effects 0.000 description 4
- 150000002334 glycols Chemical class 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 208000010744 skin desquamation Diseases 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical class O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 3
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 3
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Chemical class OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 229960004203 carnitine Drugs 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 3
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229940100554 isononyl isononanoate Drugs 0.000 description 3
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 3
- 229940100556 laureth-23 Drugs 0.000 description 3
- 229960002510 mandelic acid Drugs 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 229960001790 sodium citrate Drugs 0.000 description 3
- 239000012453 solvate Substances 0.000 description 3
- 239000001590 sorbitan monolaureate Substances 0.000 description 3
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 3
- 150000003892 tartrate salts Chemical class 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 150000003672 ureas Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- GFMYTSQFAHIXME-UHFFFAOYSA-N (2-ethylphenyl) benzoate Chemical compound CCC1=CC=CC=C1OC(=O)C1=CC=CC=C1 GFMYTSQFAHIXME-UHFFFAOYSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- ARXKVVRQIIOZGF-UHFFFAOYSA-N 1,2,4-butanetriol Chemical compound OCCC(O)CO ARXKVVRQIIOZGF-UHFFFAOYSA-N 0.000 description 2
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- VBSTXRUAXCTZBQ-UHFFFAOYSA-N 1-hexyl-4-phenylpiperazine Chemical compound C1CN(CCCCCC)CCN1C1=CC=CC=C1 VBSTXRUAXCTZBQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 2
- SXYHZEQKWNODPB-UHFFFAOYSA-N 2-[difluoro(methoxy)methyl]-1,1,1,2,3,3,3-heptafluoropropane;1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxybutane Chemical compound COC(F)(F)C(F)(F)C(F)(F)C(F)(F)F.COC(F)(F)C(F)(C(F)(F)F)C(F)(F)F SXYHZEQKWNODPB-UHFFFAOYSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- XMVBHZBLHNOQON-UHFFFAOYSA-N 2-butyl-1-octanol Chemical compound CCCCCCC(CO)CCCC XMVBHZBLHNOQON-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- WUYGEUSUCRMJJG-UHFFFAOYSA-N 3-hydroxy-3,7,11-trimethyldodecanoic acid Chemical compound CC(C)CCCC(C)CCCC(C)(O)CC(O)=O WUYGEUSUCRMJJG-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 239000004251 Ammonium lactate Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 2
- 240000008886 Ceratonia siliqua Species 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 235000017367 Guainella Nutrition 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 2
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 241000124033 Salix Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- JACRWUWPXAESPB-QMMMGPOBSA-N Tropic acid Natural products OC[C@H](C(O)=O)C1=CC=CC=C1 JACRWUWPXAESPB-QMMMGPOBSA-N 0.000 description 2
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 239000002535 acidifier Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 2
- 235000019286 ammonium lactate Nutrition 0.000 description 2
- 229940059265 ammonium lactate Drugs 0.000 description 2
- 229940051879 analgesics and antipyretics salicylic acid and derivative Drugs 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960004365 benzoic acid Drugs 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229960002173 citrulline Drugs 0.000 description 2
- 235000013477 citrulline Nutrition 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 238000000113 differential scanning calorimetry Methods 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 2
- 229950010592 dodecafluoropentane Drugs 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N ethylene glycol monomethyl ether acetate Natural products COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 239000010643 fennel seed oil Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960004275 glycolic acid Drugs 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 235000011167 hydrochloric acid Nutrition 0.000 description 2
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- 229940120511 oleyl erucate Drugs 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229960004624 perflexane Drugs 0.000 description 2
- ZJIJAJXFLBMLCK-UHFFFAOYSA-N perfluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZJIJAJXFLBMLCK-UHFFFAOYSA-N 0.000 description 2
- NJCBUSHGCBERSK-UHFFFAOYSA-N perfluoropentane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F NJCBUSHGCBERSK-UHFFFAOYSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 235000010241 potassium sorbate Nutrition 0.000 description 2
- 239000004302 potassium sorbate Substances 0.000 description 2
- 229940069338 potassium sorbate Drugs 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- 239000010668 rosemary oil Substances 0.000 description 2
- 229940058206 rosemary oil Drugs 0.000 description 2
- 239000010670 sage oil Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-N sodium;2-hydroxybenzoic acid Chemical compound [Na+].OC(=O)C1=CC=CC=C1O ABBQHOQBGMUPJH-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 229950003914 trethocanic acid Drugs 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 description 1
- OFVBXCOYANJMRT-UHFFFAOYSA-N (1-hydroxy-2-methylpropan-2-yl)urea Chemical compound OCC(C)(C)NC(N)=O OFVBXCOYANJMRT-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- XWKAVQKJQBISOL-ZETCQYMHSA-N (2s)-2-anilinopropanoic acid Chemical compound OC(=O)[C@H](C)NC1=CC=CC=C1 XWKAVQKJQBISOL-ZETCQYMHSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- RIQRGMUSBYGDBL-UHFFFAOYSA-N 1,1,1,2,2,3,4,5,5,5-decafluoropentane Chemical compound FC(F)(F)C(F)C(F)C(F)(F)C(F)(F)F RIQRGMUSBYGDBL-UHFFFAOYSA-N 0.000 description 1
- BCNXQFASJTYKDJ-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5-nonafluoro-5-(trifluoromethyl)cyclopentane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F BCNXQFASJTYKDJ-UHFFFAOYSA-N 0.000 description 1
- GRHQBTVCBZRVCM-UHFFFAOYSA-N 1,1,3,3-tetrakis(2-hydroxyethyl)urea Chemical compound OCCN(CCO)C(=O)N(CCO)CCO GRHQBTVCBZRVCM-UHFFFAOYSA-N 0.000 description 1
- OSPRSYHXEUOSQA-UHFFFAOYSA-N 1,1-bis(2-hydroxyethyl)-3,3-dimethylurea Chemical compound CN(C)C(=O)N(CCO)CCO OSPRSYHXEUOSQA-UHFFFAOYSA-N 0.000 description 1
- GBPMHVWWNARLJZ-UHFFFAOYSA-N 1,1-bis(2-hydroxyethyl)-3-propylurea Chemical compound CCCNC(=O)N(CCO)CCO GBPMHVWWNARLJZ-UHFFFAOYSA-N 0.000 description 1
- BQMXKMPREFOYHS-UHFFFAOYSA-N 1,1-bis(2-hydroxyethyl)urea Chemical compound OCCN(C(=O)N)CCO BQMXKMPREFOYHS-UHFFFAOYSA-N 0.000 description 1
- ZGLXBKOIZOVYND-UHFFFAOYSA-N 1,1-bis(2-hydroxypropyl)urea Chemical compound CC(O)CN(C(N)=O)CC(C)O ZGLXBKOIZOVYND-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- VUWCWMOCWKCZTA-UHFFFAOYSA-N 1,2-thiazol-4-one Chemical class O=C1CSN=C1 VUWCWMOCWKCZTA-UHFFFAOYSA-N 0.000 description 1
- JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical compound O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- KSYGJAFGQWTAFW-UHFFFAOYSA-N 1,3-bis(2-hydroxyethyl)urea Chemical compound OCCNC(=O)NCCO KSYGJAFGQWTAFW-UHFFFAOYSA-N 0.000 description 1
- UBZFJRDOTBGVAY-UHFFFAOYSA-N 1,3-bis(2-hydroxypropyl)urea Chemical compound CC(O)CNC(=O)NCC(C)O UBZFJRDOTBGVAY-UHFFFAOYSA-N 0.000 description 1
- SSZYXOKKPYHGLM-UHFFFAOYSA-N 1,3-dihydroxypropan-2-ylurea Chemical compound NC(=O)NC(CO)CO SSZYXOKKPYHGLM-UHFFFAOYSA-N 0.000 description 1
- 229940058012 1,3-dimethylol-5,5-dimethylhydantoin Drugs 0.000 description 1
- WGFQARDLDGTVKH-UHFFFAOYSA-N 1-(1,3-dihydroxypropan-2-yl)-3-(2-hydroxyethyl)urea Chemical compound OCCNC(=O)NC(CO)CO WGFQARDLDGTVKH-UHFFFAOYSA-N 0.000 description 1
- SMEJDOFWKJVFCT-UHFFFAOYSA-N 1-(1-hydroxy-2-methylpropan-2-yl)-3-methylurea Chemical compound CNC(=O)NC(C)(C)CO SMEJDOFWKJVFCT-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- MEEMWRUUCUSUTN-UHFFFAOYSA-N 1-ethyl-3-(2-hydroxyethyl)urea Chemical compound CCNC(=O)NCCO MEEMWRUUCUSUTN-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- SYCFORXNZREGSA-UHFFFAOYSA-N 1-methyl-1-(1,3,4,5,6-pentahydroxyhexan-2-yl)urea Chemical compound NC(=O)N(C)C(CO)C(O)C(O)C(O)CO SYCFORXNZREGSA-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 1
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 1
- RMFFCSRJWUBPBJ-UHFFFAOYSA-N 15-hydroxypentadecyl benzoate Chemical compound OCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 RMFFCSRJWUBPBJ-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- PQMAKJUXOOVROI-UHFFFAOYSA-N 2,2,3,3,5,5,6,6-octafluoro-4-(trifluoromethyl)morpholine Chemical compound FC(F)(F)N1C(F)(F)C(F)(F)OC(F)(F)C1(F)F PQMAKJUXOOVROI-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- NOFQKTWPZFUCOO-UHFFFAOYSA-N 2,2,4,4,6-pentamethylheptane Chemical compound CC(C)CC(C)(C)CC(C)(C)C NOFQKTWPZFUCOO-UHFFFAOYSA-N 0.000 description 1
- QJJLMANJJKBSNN-UHFFFAOYSA-N 2,3,4,5,6-pentahydroxyhexylurea Chemical compound NC(=O)NCC(O)C(O)C(O)C(O)CO QJJLMANJJKBSNN-UHFFFAOYSA-N 0.000 description 1
- YEDFEBOUHSBQBT-UHFFFAOYSA-N 2,3-dihydroflavon-3-ol Chemical class O1C2=CC=CC=C2C(=O)C(O)C1C1=CC=CC=C1 YEDFEBOUHSBQBT-UHFFFAOYSA-N 0.000 description 1
- IWJFGRNIFIABLP-UHFFFAOYSA-N 2,3-dihydroxypropylurea Chemical compound NC(=O)NCC(O)CO IWJFGRNIFIABLP-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- VNXWANZMRATDQM-UHFFFAOYSA-N 2-(2-phenylethyl)benzene-1,3-diol Chemical group OC1=CC=CC(O)=C1CCC1=CC=CC=C1 VNXWANZMRATDQM-UHFFFAOYSA-N 0.000 description 1
- HRWADRITRNUCIY-UHFFFAOYSA-N 2-(2-propan-2-yloxyethoxy)ethanol Chemical compound CC(C)OCCOCCO HRWADRITRNUCIY-UHFFFAOYSA-N 0.000 description 1
- HUFRRBHGGJPNGG-UHFFFAOYSA-N 2-(2-propan-2-yloxypropoxy)propan-1-ol Chemical compound CC(C)OC(C)COC(C)CO HUFRRBHGGJPNGG-UHFFFAOYSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- BDLXTDLGTWNUFM-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxy]ethanol Chemical compound CC(C)(C)OCCO BDLXTDLGTWNUFM-UHFFFAOYSA-N 0.000 description 1
- GICQWELXXKHZIN-UHFFFAOYSA-N 2-[2-[(2-methylpropan-2-yl)oxy]ethoxy]ethanol Chemical compound CC(C)(C)OCCOCCO GICQWELXXKHZIN-UHFFFAOYSA-N 0.000 description 1
- JIDBIDDEFPKZDG-UHFFFAOYSA-N 2-[[2-[n-acetyl-3-(trifluoromethyl)anilino]-3-methylbutanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)C(C(C)C)N(C(C)=O)C1=CC=CC(C(F)(F)F)=C1 JIDBIDDEFPKZDG-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- FOKDITTZHHDEHD-PFONDFGASA-N 2-ethylhexyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CC)CCCC FOKDITTZHHDEHD-PFONDFGASA-N 0.000 description 1
- LCVHZNSIAYNAGX-UHFFFAOYSA-N 2-ethylhexyl 3,5,5-trimethylhexanoate Chemical compound CCCCC(CC)COC(=O)CC(C)CC(C)(C)C LCVHZNSIAYNAGX-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- XEYIWOWYMLEPSD-UHFFFAOYSA-N 2-ethylhexyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(CC)CCCC XEYIWOWYMLEPSD-UHFFFAOYSA-N 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- VHEYHMGSWDZXEN-UHFFFAOYSA-N 2-hydroxypropylurea Chemical compound CC(O)CNC(N)=O VHEYHMGSWDZXEN-UHFFFAOYSA-N 0.000 description 1
- GMWUGZRYXRJLCX-UHFFFAOYSA-N 2-methoxypentan-2-ol Chemical compound CCCC(C)(O)OC GMWUGZRYXRJLCX-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- DUIOKRXOKLLURE-UHFFFAOYSA-N 2-octylphenol Polymers CCCCCCCCC1=CC=CC=C1O DUIOKRXOKLLURE-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 1
- CYSSSYKSBHKJQE-UHFFFAOYSA-N 2-undecylpentadecan-1-ol Chemical compound CCCCCCCCCCCCCC(CO)CCCCCCCCCCC CYSSSYKSBHKJQE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AWNNECGZCPBURJ-UHFFFAOYSA-N 3-(2-hydroxyethyl)-1,1-bis(2-hydroxypropyl)urea Chemical compound CC(O)CN(CC(C)O)C(=O)NCCO AWNNECGZCPBURJ-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- DNPHEDNKXRMPAX-UHFFFAOYSA-N 3-hydroxypropylurea Chemical compound NC(=O)NCCCO DNPHEDNKXRMPAX-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- GBSGXZBOFKJGMG-UHFFFAOYSA-N 3-propan-2-yloxypropan-1-ol Chemical compound CC(C)OCCCO GBSGXZBOFKJGMG-UHFFFAOYSA-N 0.000 description 1
- TXDXRHGRYPYKHB-UHFFFAOYSA-N 3-tert-butyl-1-(2-hydroxyethyl)-1-(2-hydroxypropyl)urea Chemical compound CC(O)CN(CCO)C(=O)NC(C)(C)C TXDXRHGRYPYKHB-UHFFFAOYSA-N 0.000 description 1
- TZZGHGKTHXIOMN-UHFFFAOYSA-N 3-trimethoxysilyl-n-(3-trimethoxysilylpropyl)propan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCCC[Si](OC)(OC)OC TZZGHGKTHXIOMN-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- AMOCOBXCNIBDMC-UHFFFAOYSA-N 4-Methyl-1,2-dihydroxypentane Chemical compound CC(C)CC(O)CO AMOCOBXCNIBDMC-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- PCUXMDACXTVDGR-UHFFFAOYSA-N 4-methylpentyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCOC(=O)C(C)(C)C PCUXMDACXTVDGR-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 235000014722 Aralia cordata Nutrition 0.000 description 1
- 244000024251 Aralia cordata Species 0.000 description 1
- 235000004446 Aralia racemosa Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000612703 Augusta Species 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- GZYFIMLSHBLMKF-REOHCLBHSA-N L-Albizziine Chemical compound OC(=O)[C@@H](N)CNC(N)=O GZYFIMLSHBLMKF-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 235000010658 Lavandula latifolia Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 240000002817 Leonurus sibiricus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- PVCJKHHOXFKFRP-UHFFFAOYSA-N N-acetylethanolamine Chemical compound CC(=O)NCCO PVCJKHHOXFKFRP-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 240000002690 Passiflora mixta Species 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 235000005105 Pinus pinaster Nutrition 0.000 description 1
- 241001236212 Pinus pinaster Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000000657 Rosa moschata Nutrition 0.000 description 1
- 244000018676 Rosa sp Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 229910018557 Si O Inorganic materials 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- IVSHBCMTAKLBIE-UHFFFAOYSA-N [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]urea Chemical compound NC(=O)NC(CO)(CO)CO IVSHBCMTAKLBIE-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- PDWFFEHBPAYQGO-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-hexyl-dimethylsilane Chemical compound CCCCCC[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C PDWFFEHBPAYQGO-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
- 229940108929 alfalfa oil Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229930015036 aurone Natural products 0.000 description 1
- 150000001530 aurones Chemical class 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000000842 betacyanins Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229940094199 black currant oil Drugs 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000001342 boswellia carteri birdw. oil Substances 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 244000192479 candlenut Species 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 239000010627 cedar oil Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 150000001789 chalcones Chemical class 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical compound OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001111 citrus aurantium l. leaf oil Substances 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010633 clary sage oil Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000001555 commiphora myrrha gum extract Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- 125000005534 decanoate group Chemical class 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- FBZANXDWQAVSTQ-UHFFFAOYSA-N dodecamethylpentasiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C FBZANXDWQAVSTQ-UHFFFAOYSA-N 0.000 description 1
- 229940087203 dodecamethylpentasiloxane Drugs 0.000 description 1
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 229940100549 ethylhexyl isononanoate Drugs 0.000 description 1
- 229940095139 ethylhexyl laurate Drugs 0.000 description 1
- 229940096388 ethylhexyl oleate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 150000002193 fatty amides Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 235000003248 hydroxytyrosol Nutrition 0.000 description 1
- 229940095066 hydroxytyrosol Drugs 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940102253 isopropanolamine Drugs 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940073577 lithium chloride Drugs 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229930014802 neoflavonoid Natural products 0.000 description 1
- 150000002804 neoflavonoids Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- HRPZGPXWSVHWPB-UHFFFAOYSA-N octyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCCCCC HRPZGPXWSVHWPB-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- LOQGSOTUHASIHI-UHFFFAOYSA-N perfluoro-1,3-dimethylcyclohexane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(C(F)(F)F)C1(F)F LOQGSOTUHASIHI-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 229940106587 pine bark extract Drugs 0.000 description 1
- 235000020741 pine bark extract Nutrition 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 description 1
- 235000007221 pinoresinol Nutrition 0.000 description 1
- 239000001631 piper nigrum l. fruit oil black Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 108010011110 polyarginine Proteins 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- XLCIFRJORZNGEV-UHFFFAOYSA-N propan-2-yl 2-[dodecanoyl(methyl)amino]acetate Chemical compound CCCCCCCCCCCC(=O)N(C)CC(=O)OC(C)C XLCIFRJORZNGEV-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000008171 pumpkin seed oil Substances 0.000 description 1
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical compound [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 229960002026 pyrithione Drugs 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000010493 quinoa oil Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010669 rosewood oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000010671 sandalwood oil Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003436 stilbenoids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- GVPDNFYOFKBFEN-UHFFFAOYSA-N trimethyl(octadecoxy)silane Chemical compound CCCCCCCCCCCCCCCCCCO[Si](C)(C)C GVPDNFYOFKBFEN-UHFFFAOYSA-N 0.000 description 1
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000010679 vetiver oil Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/884—Sequential application
Definitions
- compositions for topical application to keratinous tissue, particularly compositions that include urea in high amounts, and compositions that include urea in high amounts together with actives for which the urea may provide stabilization and or boosted efficacy.
- BACKGROUND Many cosmetic compositions are provided with select actives that provide any number of benefits, for example, including, but not limited to, skin desquamation (peeling).
- Urea is a commonly used ingredient as a humectant.
- High concentrations of urea for skin care are desirable for the humectant properties, including as a means to promote the stratum corneum to swell, and for stimulating skin desquamation.
- Urea is found in many compositions that include other skin actives.
- Various compositions that may include high concentrations of urea for skin care are thus desirable for the humectant properties.
- Such skin care compositions would beneficially include urea or a derivative thereof in a range from about 20% to 40% by weight of the composition.
- topical preparations that contain high concentrations of urea present many challenges
- One challenge relates to the tendency of urea to undergo a continuous hydrolysis reaction that leads to pH increase, which can result in an increase from a pH of about 7 up to a pH of 9 or greater over the course of storage.
- Such pH values at or greater than a pH of 8 are much higher than that of the natural skin, which is about 5.5, and compositions with a pH in this range would likely cause skin irritation when applied.
- Such high resultant pH renders most formulations unsuitable for use on skin, particularly in water-based compositions which don’t provide protection through barrier forming oils and butters. This is particularly an issue for water-based leave-on compositions.
- Yet another challenge is the tendency of urea to crystalize at high concentrations and at low temperature over time. This crystallization would be expected to reduce the amount of active urea available in the usable composition, thus diminishing the overall desired efficacy of the product.
- a further challenge with high urea content is whitening of the skin which is not aesthetically pleasing to many consumers.
- the inventors provide here a cosmetic skin care composition comprising a skin conditioning composition that is used in some embodiments for skin rejuvenation that includes use of the skin conditioning composition followed by use of a secondary complementary composition.
- the inventors have overcome the foregoing challenges and provide a water-based skin conditioning composition that supports and, in some particular embodiments, boosts the activity of skin actives.
- the skin conditioning composition is stable from pH increase and crystallization to maintain a high amount of urea for achieving efficacy as a humectant, for promoting the stratum corneum to swell, and for stimulating skin desquamation, among other possible benefits.
- the disclosure provides a cosmetic skin care composition comprising a skin conditioning composition with high urea content in different formats selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover.
- an inventive skin conditioning composition may be used alone or as a first step prior to application of a secondary complementary composition comprising one or more actives, such as a hydroxy acid or other water soluble actives.
- the inventive composition my boost the efficacy of the active or actives, for example for skin rejuvenation or conditioning.
- a skin conditioning composition that includes a carrier system having a water phase, the water phase including urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of the skin conditioning composition is less than about 7.
- the skin conditioning composition carrier system may also include one more additional ingredients, each present in the water phase or in a second phase.
- the invention provides a skin conditioning composition, comprising: urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of the skin conditioning composition is less than about 7.
- the composition is formulated as a leave-on product.
- the at least one amnio acid is soluble in water at a pH from about 4 to about 6.
- the at least one amnio acid is selected from the group consisting of glycine, proline, serine, cysteine and combinations thereof.
- the at least one amnio acid is present in an amount from about 5% to about 9%, by weight, based on the weight of the composition.
- the at least one of triacetin or triethyl citrate is present in an amount from about 0.2% to about 2%%, by weight, based on the weight of the composition.
- the invention provides a skin conditioning composition wherein the at least one amino acid is selected from the group consisting of glycine, proline, serine, cysteine and combinations thereof and is present in an amount from about 5% to about 9%, by weight, based on the weight of the composition; and the at least one of triacetin or triethyl citrate, is present in an amount a range that includes about 0.2% to about 2%, by weight, based on the weight of the composition; and wherein the skin conditioning composition comprises a buffer system comprising one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof, wherein the skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 o C up to 45 o C and through freeze thaw cycles from -20 o C through 20 o C, characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH
- the skin conditioning composition further comprising at least one pH adjusting reagent comprising triethanolamine.
- the urea or a derivative thereof is present in an amount from greater than about 20% to about 40%, by weight, based on the weight of the composition, and further comprising at least one glycol selected from the group consisting of propylene glycol, glycerin, and combinations thereof.
- the skin conditioning composition comprises propylene glycol and excludes glycerin.
- the invention provides a skin conditioning composition, comprising: urea present from greater than 20% to about 40%; at least one amino acid, the at least one amino acid comprising glycine present from about 5% to about 9%; at least one of triacetin or triethyl citrate, present from about 0.2% to about 2%; a buffer system having a pH in a range from about 4.0 to about 6.0; at least one pH adjusting reagent, comprising triethanolamine; and at least one glycol selected from the group consisting of propylene glycol, glycerin, and combinations thereof, wherein all amounts are by weight, based on the weight of the composition, and wherein the pH is from about 4.0 to about 6.0, and wherein the skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 o C up to 45 o C and through freeze thaw cycles from -20 o C through 20 o C, characterized as the absence of any or sustained visible crystall
- the skin conditioning composition comprises propylene glycol and excludes glycerin.
- the buffer system comprises one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof.
- the buffer system comprises sodium lactate and lactic acid.
- the invention provides a skin conditioning composition, comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of The skin conditioning composition is less than about 7.
- the carrier system further comprises one more additional ingredients, each present in the water phase or in a second phase.
- the one or more additional ingredients includes one or more of an additional ingredient selected from the group consisting of a skin active compound, a humectant in addition to any glycol, an oil, a surfactant, a thickener, a preservative, and combinations thereof.
- the skin conditioning composition is one of a single phase solution comprising the water phase, a multi-phase solution comprising at least one additional phase, or an emulsion comprising at least one oily phase.
- the skin conditioning composition is a product for keratinous tissue selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover.
- the skin conditioning composition is a leave-on formulation.
- the present disclosure provides a method of contacting a portion of skin with skin conditioning composition with or without an implement or an applicator. The methods may further include application of a complementary composition, before or after application of the skin conditioning composition.
- a home use skin conditioning composition with high urea content in different formats selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover.
- the skin conditioning composition is used as first step prior to application of a complementary composition comprising one or more actives, such as a hydroxy acid or other water soluble actives, to boost the efficacy of the active or actives, for example for skin rejuvenation.
- a method of use includes application of the skin conditioning composition as a leave on for providing moisture retention benefits.
- a method of use includes application of the skin conditioning composition as a leave on, followed by application, of a complementary composition, such as, but not limited to, a complementary composition containing one or more actives that can complement or supplement the benefits of the skin conditioning composition.
- a complementary composition such as, but not limited to, a complementary composition containing one or more actives that can complement or supplement the benefits of the skin conditioning composition.
- the disclosure provides a system (or kit) employing the skin conditioning composition and one or more complementary compositions comprising one or more actives, such as a hydroxy acid or other water soluble actives.
- the disclosure provides a regimen employing the skin conditioning composition.
- the regimen includes application, in one, two, three or more application steps of a first composition comprising at least one of the skin conditioning composition and a complementary composition, and a second composition comprising at least one of the skin conditioning composition and a complementary composition.
- the first and second compositions are different.
- the first and second compositions are the same.
- the first composition comprises the skin conditioning composition
- the second composition comprises the complementary composition.
- the first composition comprises the complementary composition
- the second composition comprises the skin conditioning composition.
- Application may include three or more sequential steps where first and second compositions are applied in any order.
- both compositions are either left on the skin or may be removed by rinsing.
- the application of one or both may include use of an implement such as a brush.
- the present disclosure provides a method of contacting a portion of skin with skin conditioning composition with or without an implement or an applicator. The methods may further include application of a complementary composition, before or after application of the skin conditioning composition.
- a method improving the efficacy of a skin care active comprising: a) applying to a region of skin a first composition comprising a skin conditioning composition comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH is less than about 7; b) applying to the region of skin a second composition comprising complementary composition comprising one or more skin actives not present in the skin conditioning composition.
- a skin conditioning composition comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or
- the steps of the method include (a) and (b) in any order.
- each of the compositions is aqueous and is applied in liquid form.
- the first composition is one of a water- based toner or a mask.
- the first composition is a water-based toner that is applied first followed by the second composition without prior removal of the first composition.
- the first composition is a water-based mask that is applied first followed by the second composition, the method further comprising a step that includes rinsing to remove the first composition prior to application of the second composition.
- one or both of the first and second compositions is coupled to an application surface of an applicator, the application surface selected from the group consisting of a bristle surface of a brush, a roller surface of a rolling applicator, and a blade surface of a spatula
- an article of manufacture for providing a skin system for improving the efficacy of a skin care active comprising: at least first and second separately contained compositions.
- the first composition comprising a skin conditioning composition
- a skin conditioning composition comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH is less than about 7, and the second composition comprising a complementary composition comprising one or more skin actives not present in the skin conditioning composition.
- the first and second compositions are one of (i) contained to be mixable prior to application to skin, and (ii) contained to be applied separately, in any order.
- one or both compositions may be coupled to an application surface of an applicator.
- the application surface may be a surface of a mask configured to conform to a face of a wearer.
- the application surface may be selected from the group consisting of a bristle surface of a brush, a roller surface of a rolling applicator, and a blade surface of a spatula.
- the skincare formulation may be disposed in a first compartment of a sachet and the application surface may be a surface of a second compartment of the sachet, and wherein the first compartment and the second compartment are fluidically separated by a breakable barrier.
- FIG. 1 is a bar graph that shows stratum corneum test results demonstrating the comparative efficacy of the inventive composition used according to the inventive methods as compared with controls.
- FIG. 2 is a bar graph that shows stratum corneum test results demonstrating the comparative efficacy of the inventive composition at different concentrations of urea and used according to the inventive methods as compared with controls.
- FIG. 3 is a bar graph that shows stratum corneum test results demonstrating the comparative efficacy of the inventive composition employing different forms of urea and used according to the inventive methods as compared with controls.
- the skin conditioning composition of the present invention may be used for the production of cosmetic preparations, or dermatological preparations, more particularly topical treatment preparations, that may be formulated as single-phase water-based solution compositions, cosmetic serums, or aerosols, for example.
- Topical application to a surface may be a surface such as the mucus membrane or the skin, for example.
- the disclosure provides a cosmetic skin care composition comprising a skin conditioning composition with high urea content in different formats selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover.
- an inventive skin conditioning composition may be used alone or as a first step prior to application of a secondary complementary composition comprising one or more actives, such as a hydroxy acid or other water soluble actives.
- the inventive composition my boost the efficacy of the active or actives, for example for skin rejuvenation or conditioning.
- skin conditioning and “skin rejuvenation” in reference to the inventive skin conditioning composition means acting as a humectant as a means to promote the stratum corneum to swell, and for stimulating skin desquamation.
- the skin conditioning composition is especially useful according to methods for rejuvenation including application of the skin conditioning composition to promote the stratum corneum of skin to swell to thereby stimulate the skin to be responsive to a secondary treatment.
- Cosmetically acceptable means compatible with any keratinous substrate.
- cosmetically acceptable carrier means a carrier that is compatible with any keratinous substrate.
- stable as used in reference to the structural or solubility state of the ingredients of the skin conditioning composition means that the skin conditioning composition lacks crystal formation that is visible to the naked eye, and does not demonstrate visually perceptible crystal formation over a period of time, for example for one, two or four or five days, or for a period of one or more weeks, and for example up to eight (8) weeks, and wherein when crystals are visualized at a temperature at or below 4 °C, such crystals disappear with or without mild agitation within 24 hours of reaching an ambient temperature from about 25 °C up to about 37 °C and after freeze thaw cycles from -20 o C through 20 o C.
- the term “stable” as used in reference to the pH the skin conditioning composition means that the pH does not increase appreciably over time, for example as described in the examples herein.
- the term “leave-on” as used herein refers to a composition which is applied and is not removed by wiping or rinsing with water.
- the disclosure provides a home use skin conditioning composition with high urea content in different formats selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover.
- the skin conditioning composition is used as first step prior to application of a complementary composition comprising one or more actives, such as a hydroxy acid or other water soluble actives, to boost the efficacy of the active or actives, for example for skin rejuvenation.
- a skin rejuvenation or skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 o C up to 45 o C and through freeze thaw cycles from -20 o C through 20 o C.
- the stabilities are characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7, and in some particular embodiments that include greater than 20% and up to at least 40% urea.
- the composition can surprisingly improve the efficacy of a second complimentary composition that includes at least one skin active.
- the skin conditioning composition stabilities are characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7, in particular in embodiments that include greater than 20% and up to at least 40% urea. Examples provided herein demonstrate these and other aspects of the unexpected properties of the skin conditioning composition.
- the invention also provides methods of use of the skin conditioning composition for rejuvenation of the skin.
- a method of use includes application of the skin conditioning composition as a leave on for providing moisture retention benefits.
- a method of use includes application of the skin conditioning composition as a leave on, followed by application, of a complementary composition, such as, but not limited to, a complementary composition containing one or more actives that can complement or supplement the benefits of the skin conditioning composition.
- a complementary composition such as, but not limited to, a complementary composition containing one or more actives that can complement or supplement the benefits of the skin conditioning composition.
- the disclosure provides a system (or kit) employing the skin conditioning composition and one or more complementary compositions comprising one or more actives, such as a hydroxy acid or other water soluble actives.
- the disclosure provides a regimen employing the skin conditioning composition.
- the regimen includes application, in one, two, three or more application steps of a first composition comprising at least one of the skin conditioning composition and a complementary composition, and a second composition comprising at least one of the skin conditioning composition and a complementary composition.
- the first and second compositions are different.
- the first and second compositions are the same.
- the first composition comprises the skin conditioning composition
- the second composition comprises the complementary composition.
- the first composition comprises the complementary composition
- the second composition comprises the skin conditioning composition.
- Application may include three or more sequential steps where first and second compositions are applied in any order.
- both compositions are either left on the skin or may be removed by rinsing.
- the application of one or both may include use of an implement such as a brush.
- Skin conditioning composition is formed by providing the carrier system having a water-phase that comprises water.
- the carrier system may further comprise one more additional ingredients, each present in the water phase or in another phase, such as an oily phase.
- the one or more additional ingredients includes one or more of an additional ingredient selected from the group consisting of a skin active compound, humectant in addition to any glycol, a preservative, a surfactant, a thickener, and combinations thereof.
- the skin conditioning composition may include one or more of any one of the additional ingredients.
- the skin conditioning composition may also include fragrances, pH adjusters, other cosmetically acceptable additives, or a combination thereof.
- the skin conditioning composition may be any suitable form, such as, but not limited to, a single phase solution comprising the water phase, a multi-phase solution comprising at least one water phase, an emulsion comprising a water phase and an oily phase, such as, but not limited to, a water-in-oil emulsion, an oil-in-water emulsion, or a silicone-in-water emulsion.
- the skin conditioning composition may be provided in a product form for application to keratinous tissue, such as, but not limited to, a skin care product or a hair care product, and may be a product form such as, but not limited to, a micellar water, a cream or lotion, a toner, a cleanser, or a make-up remover.
- the skin conditioning composition in any of the product forms may be either a leave-on or a rinse-off formulation. In certain embodiments, as exemplified herein, the skin conditioning composition is a leave-on formulation.
- the skin conditioning composition includes a carrier system having a water phase, the water phase including urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of the skin conditioning composition is less than about 7.
- the skin conditioning composition carrier system may also include one more additional ingredients, each present in the water phase or in a second phase.
- the skin conditioning composition includes urea present in an amount sufficient to enhance penetration of the active ingredient(s).
- urea may be provided as one of urea, or a urea derivative, for example, hydroxyethyl urea (HEU), wherein urea has a formula (I) and HEU has a formula (II) as shown below.
- HEU hydroxyethyl urea
- a urea or a derivative thereof is selected for its beneficial effects to the skin, which effect is to be enhanced by exposure to urea of the viable epidermis and/or dermis, which underlies the stratum corneum, wherein a urea derivative can be described by the general formula (III): R 1 R 2 N—C( ⁇ O)—NR 3 R 4 (III) wherein R1, R2, R3 and R4 each represent, independently of each other, a hydrogen atom, a C1-C4 alkyl group or a C2-C6 hydroxyalkyl group which optionally contains from 1 to 5 hydroxyl groups, where at least one of the radicals R1 to R4 represents a hydroxyalkyl group, and their salts, their solvates and their isomers in a composition containing a physiologically acceptable medium, as agent intended for stimulating desquamation of the skin and/or the mucous membranes and/or the superficial body growths.
- R denotes a C2-C6 hydroxyl group
- R2, R3 and R4 denote, independently of each other, a hydrogen atom or a C1-C4 alkyl group.
- R1 denotes a C2-C6 hydroxyalkyl group comprising from 1 to 5 hydroxyl groups, in particular 1 hydroxyl group
- R2, R3 and R4 denote a hydrogen atom.
- R1 denotes a C2-C4 hydroxyalkyl group comprising 1 hydroxyl group
- R2, R3 and R4 denote a hydrogen atom.
- alkyl groups there may be mentioned in particular methyl, ethyl, n- propyl, isopropyl, n-butyl, isobutyl and tert-butyl groups.
- hydroxyalkyl groups those containing a single hydroxyl group are preferred, and in particular the hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl and hydroxyhexyl groups, are preferred.
- salts there may be mentioned in particular the salts of inorganic acids, such as sulphuric acid, hydrochloric acid, hydrobromic acid, hydriodic acid, phosphoric acid and boric acid.
- organic acids which may contain one or more carboxylic, sulphonic or phosphonic acid groups. They may be linear, branched or cyclic aliphatic acids or aromatic acids. These acids may additionally contain one or more heteroatoms chosen from O and N, for example in the form of hydroxyl groups. There may be mentioned in particular propionic acid, acetic acid, terephthalic acid, citric acid and tartaric acid.
- the expression solvate is understood to mean a stoichiometric mixture of the said compound of formula (III) with one or more molecules of water or of organic solvent, such a mixture typically being obtained from the synthesis of the compound of formula (III).
- N-(2-hydroxyethyl)urea N- (2-hydroxypropyl)-urea; N-(3-hydroxypropyl)urea; N-(2,3-dihydroxypropyl)-urea; N-(2,3,4,5,6- pentahydroxyhexyl)urea; N-methyl-N-(1,3,4,5,6-pentahydroxy-2-hexyl)urea; N-methyl-N′-(1- hydroxy-2-methyl-2-propyl)urea; N-(1-hydroxy-2-methyl-2-propyl)urea; N-(1,3-dihydroxy-2- propyl)urea; N-(tris-hydroxymethylmethyl)urea; N-ethyl-N′-(2-hydroxyethyl)urea; N,N-bis(2- hydroxyethyl)urea; N,N′-bis(2-hydroxyethyl)urea; N,N-bis(2-hydroxyethyl)urea; N,N′-bis(
- total amount of the urea or derivative thereof is in a range from about 20% to about 40%, or from about 20% to about 35%, or from about 25% to about 30%, or from about 25% to about 40%, or from about 30% to about 35% or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the composition.
- total amount of the urea or derivative thereof is in a range from about 20% to about 40%, or from about 20% to about 35%, or from about 25% to about 30%, or from about 25% to about 40%, or from about 30% to about 35% or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the composition.
- the urea or derivative thereof is present, by weight, based on the total weight of the composition, from about 20, 21, 22, 23, 24, 25,26,27,28, 29, 30, 31,32, 33, 34, 35,36,37, 38, 39 to about 40 weight percent, including increments and ranges therein and there between.
- Amino Acid [0089]
- the skin conditioning composition includes at least one or more amino acids.
- the at least one amino acid may be selected from the group consisting of naturally occurring amino acids.
- the at least one amino acid may be selected from glycine, proline, serine and cysteine.
- the at least one amino acid comprises glycine.
- the amino acids that may be used may be of natural or synthetic origin, in L, D, or racemic form, and comprise at least one acid function chosen from, for instance, carboxylic acid, sulfonic acid, phosphonic acid, and phosphoric acid functions.
- the amino acids may be in their neutral or ionic form.
- Polymeric forms are also useful, such as poly arginine, poly lysine, etc.
- Additional non-limiting examples include basic amino acids comprising an additional amine function optionally included in a ring or in a ureido function.
- amino acids that may be used include, but are not limited to, aspartic acid, glutamic acid, alanine, arginine, ornithine, citrulline, asparagine, carnitine, cysteine, glutamine, glycine, histidine, lysine, isoleucine, leucine, methionine, N-phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine, ornithine, citrulline, and valine.
- the amount of amnio acid present in a composition according to the disclosure can range from about 2% to about 10%, or from about 3% to about 9%, or from about 4% to about 8%, or from about 3% to about 5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the composition.
- the composition includes at least about 3%, or at least about 5% of the at least one amino acid.
- the composition includes not more than about 9% of the at least one amino acid.
- the skin conditioning composition includes at least one or more of triacetin or triethyl citrate.
- the amount of triacetin or triethyl citrate present in a composition according to the disclosure can range from about 0.2% to about 2%, or from about 0.3% to about 1.5%, or from about 0.5% to about 1.2%, or from about 0.7% to about 1%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- the skin conditioning composition includes at least about 0.2%, or at least about 0.7% of the triacetin or triethyl citrate.
- the skin conditioning composition includes not more than about 1% of the triacetin or triethyl citrate.
- any one of or a combination of the triacetin or triethyl citrate may be present, by weight, based on the total weight of the skin conditioning composition, or from about 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, to about 2 weight percent, including increments and ranges therein and there between.
- the skin conditioning composition may include a buffer system.
- the buffer system comprises one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof. In some particular embodiments, the buffer system comprises sodium lactate, lactic acid, ammonium lactate, and combinations thereof. In some particular embodiments, the buffer system comprises citric acid, sodium citrate, and combinations thereof. [0099] More generally, the buffer system is selected from conventional buffer systems commonly used for compositions used on keratinous tissue, particularly skin. Buffer systems may include one or a combination of acidifying agents and alkalifying agents.
- Acidifying agents include, for example, organic or inorganic acids such as hydrochloric acid, orthophosphoric acid, sulphuric acid, carboxylic acids such as acetic acid, tartaric acid, citric acid and lactic acid, and sulphonic acids.
- Alkalifying agents include, for example, aqueous ammonia, alkali metal carbonates, alkanolamines such as mono-, di- and triethanolamines and their derivatives, sodium hydroxide or potassium hydroxide.
- a buffer system comprising, for example, sodium lactate, lactic acid, ammonium lactate, and combinations thereof, includes each of the buffer system components present in a range from about 0.1% to about 3%, or from about 0.25% to about 2.5%, or from a total of about 0.1% to about 6%, or from about 0.25% to about 5.25%, or any suitable combination, sub-combination, range, or sub- range thereof by weight, based on the weight of the skin conditioning composition. More generally, in some embodiments according to the disclosure, the skin conditioning composition includes each one or more buffer components present in a range from about 0.1% to about 15%.
- any one of or a combination of buffer system components may be present, by weight, based on the total weight of the skin conditioning composition, or from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,12, 13, 14, to about 15 weight percent, including increments and ranges therein and there between.
- the skin conditioning composition may include at least one alkanol, and particularly at least one glycol.
- the skin conditioning comprises one or a combination of alkanols (polyhydric alcohols such as glycols and polyols).
- the skin conditioning comprises one or a combination of propylene glycol, glycerin, propanediol, butylene glycol, dipropylene glycol, pentylene glycol, hexylene glycol, ethoxydiglycol, and combinations thereof.
- the skin conditioning may comprise at least propylene glycol, with or without glycerin.
- the skin conditioning may comprise one or a combination of the 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, diethylene glycol, butylene glycol, hexylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 1,3-butanediol, 2,3-butanediol, 1,4-butanediol, 3-methyl-1,3-butanediol, 1,5- pentanediol, tetraethylene glycol, 1,6-hexanediol, 2-methyl-2,4-pentanediol, polyethylene glycol, 1,2,4-butanetriol, 1,2,6-hexanetriol, 2-butene-1,4-diol, 2-ethyl-1,3-hexanediol, 2-methyl- 2,4-pentanediol, (capryly
- the amount of the at least one glycol present in the skin conditioning composition can range from about 1% to about 15%, or from about 2% to about 12%, or from about 3% to about 10%, or from about 3.5% to about 5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- the amount of the at least one glycol present in the skin conditioning composition can range from about 1% to about 15%, or from about 2% to about 12%, or from about 3% to about 10%, or from about 3.5% to about 5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- any one of or a combination of glycol, when present, may be present, by weight, based on the total weight of the skin conditioning composition, is from about 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10, 10.5, 11, 11.5, 12, 12.513, 13.5, 14, 14.5, to about 15 percent, by weight, based on the weight of the skin conditioning composition, including increments and ranges therein and there between.
- the skin conditioning composition is formed by providing a carrier system having a water-phase that comprises water.
- the urea, amino acid, triacetin/Triethyl citrate, and buffer system components are typically preferentially in the water phase.
- the skin conditioning composition may include other ingredients, and the carrier system may include other phases, including one or more additional water and/or oil phases.
- Water Phase/Water In various embodiments, the skin condition composition includes at least one water phase that includes water. [00111]
- the skin conditioning composition comprises from about 40% to about 70% by weight of water, with respect to the total weight of the skin conditioning composition.
- the amount of water in the skin conditioning composition can range from about 40% to about 70%, or from about 45% to about 65%, or from about 50% to about 60%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- the pH of the skin conditioning composition is in the range from and including about 4 to about 6, and in some embodiments is one of between 5.5 and 6.5, or between 4 and 5, or between 5 and 6, or up to about 7.
- the pH can be adjusted to the desired value by addition of a base (organic or inorganic) to the skin conditioning composition, for example ammonia or a primary, secondary or tertiary (poly)amine, such as monoethanolamine, diethanolamine, triethanolamine, isopropanolamine or 1,3-propanediamine, or alternatively by addition of an inorganic or organic acid, for example a carboxylic acid, such as, for example, citric acid.
- a base organic or inorganic
- a primary, secondary or tertiary (poly)amine such as monoethanolamine, diethanolamine, triethanolamine, isopropanolamine or 1,3-propanediamine
- an inorganic or organic acid for example a carboxylic acid, such as, for example, citric acid.
- water may be present by weight, based on the total weight of the skin conditioning composition, or from about 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, to about 70 weight percent, including increments and ranges therein and there between.
- Optional Components [00115] Cosmetic Oils/Emollients
- the skin conditioning composition may comprise at least one oily phase which may include any one or a combination of cosmetic oils.
- the oil is generally immiscible in water.
- the oil may be selected from hydrocarbons, silicones, fatty alcohols, glycols, and vegetable oils.
- the oil may include one or a combination of polar and non-polar oil.
- the oil may be chosen from hydrocarbon-based oils from plants or of plant origin, mineral oil, ester oils, fatty alcohols containing from 12 to 26 carbon atoms, fatty acids containing from 12 to 26 carbon atoms and vinylpyrrolidone copolymers, and combinations thereof.
- the oil may be selected from the group consisting of, coco-caprylate/caprate, dicaprylyl carbonate, dicaprylyl ether, isopropyl palmitate, and combinations thereof.
- Silicone oil relates to oil comprising at least one silicon atom, and especially at least one Si-O group.
- fluoro oil relates to oil comprising at least one fluorine atom.
- hydrocarbon-based oil relates to oil comprising mainly hydrogen and carbon atoms. Hydrocarbon-based oil may be animal hydrocarbon-based oil, plant hydrocarbon-based oil, mineral hydrocarbon-based oil, or a synthetic hydrocarbon-based oil. Further, suitable oil may be a mineral hydrocarbon-based oil, a plant hydrocarbon-based oil, or a synthetic hydrocarbon-based oil.
- the skin conditioning composition may comprise one or more silicone oils.
- Non- limiting examples of silicone oils include dimethicone, cyclomethicone, polysilicone-11, phenyl trimethicone, trimethylsilylamodimethicone, and stearoxytrimethylsilane.
- the skin conditioning composition includes dimethicone, and optionally additional oils, including additional silicone oils.
- the one or more silicone oils is a non-volatile silicon oil.
- the silicone oil is polydimethylsiloxanes (PDMSs), polydimethylsiloxanes comprising alkyl or alkoxy groups which are pendent and/or at the end of the silicone chain, which groups each contain from 2 to 24 carbon atoms, or phenyl silicones, such as phenyl trimethicones, phenyl dimethicones, phenyl(trimethylsiloxy)diphenylsiloxanes, diphenyl dimethicones, diphenyl(methyldiphenyl)trisiloxanes or (2-phenylethyl)trimethylsiloxysilicates.
- PDMSs polydimethylsiloxanes
- phenyl silicones such as phenyl trimethicones, phenyl dimethicones, phenyl(trimethylsiloxy)diphenylsiloxanes, diphenyl dimethicones, diphenyl(methyldiphenyl)trisi
- silicone oils that may be mentioned include volatile linear or cyclic silicone oils, especially those with a viscosity 8 centistokes (8x106 m2/s) and especially containing from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups containing from 1 to 10 carbon atoms.
- the skin conditioning composition may comprise one or more fluoro oils.
- the one or more fluoro oil may be selected from the group consisting of perfluoromethylcyclopentane, perfluoro-1,3-dimethylcyclohexane, dodecafluoropentane, tetradecafluorohexane, bromoperfluorooctyl, nonafluoromethoxybutane, nonafluoroethoxyisobutane and 4-trifluoromethylperfluoromorpholine.
- Volatile fluoro oils such as nonafluoromethoxybutane, decafluoropentane, tetradecafluorohexane, dodecafluoropentane, may also be used.
- the skin conditioning composition may comprise one or more hydrocarbon-based oils.
- the hydrocarbon-based oil may be a saturated hydrocarbon, an unsaturated hydrocarbon, lipids, triglycerides, a natural oil, and/or a synthetic oil.
- the skin conditioning composition may include a synthetic oil selected from the group consisting of hydrogenated polyisobutene and hydrogenated polydecene.
- a hydrocarbon- based oil may be a non-volatile hydrocarbon-based, such as: (i) hydrocarbon-based oils of plant origin, such as glyceride triesters, which are generally triesters of fatty acids and of glycerol, the fatty acids of which can have varied chain lengths from C4 to C24, it being possible for these chains to be saturated or unsaturated and linear or branched; these oils are in particular wheat germ oil, sunflower oil, grape seed oil, sesame oil, corn oil, apricot oil, castor oil, shea oil, avocado oil, olive oil, soybean oil, sweet almond oil, palm oil, rapeseed oil, cottonseed oil, hazelnut oil, macadamia oil, jojoba oil, alfalfa oil, poppy oil, pumpkin seed oil, marrow oil, blackcurrant oil, evening primrose oil, millet oil, barley oil, quinoa oil, rye oil, safflower oil, candlenut oil, passionflower oil, and
- Hydrocarbon-based oils may be glyceride triesters and in particular to caprylic/capric acid triglycerides, synthetic esters and in particular isononyl isononanoate, oleyl erucate, C12- C15 alkyl benzoate, 2-ethylphenyl benzoate and fatty alcohols, such as octyldodecanol.
- hydrocarbon-based oils containing from 8 to 16 carbon atoms and in particular of branched C8-C16 alkanes, such as C8-C16 isoalkanes of petroleum origin (also known as isoparaffins), such as isododecane (also known as 2,2,4,4,6- pentamethylheptane), isodecane or isohexadecane, the oils sold under the Isopar or Permethyl trade names, branched C C8-C16 esters, and isohexyl neopentanoate.
- C8-C16 alkanes such as C8-C16 isoalkanes of petroleum origin (also known as isoparaffins), such as isododecane (also known as 2,2,4,4,6- pentamethylheptane), isodecane or isohexadecane, the oils sold under the Isopar or Permethyl trade names, branched C C8-C16 esters, and iso
- the skin conditioning composition may comprise one or more oils such as from those described herein above, and from oils that may be selected from branched or linear, liquid alkane with carbon chain length of C11 to C20.
- liquid alkanes may be selected from those with a carbon chain length of from C11 to C20.
- the liquid alkanes may be selected from those with a carbon chain length of from C11 to C20, or from C15 to C19, or one of C11, C12, C13, C14, C15, C16, C17, C18 to C19.
- suitable liquid alkanes that may be used according to the disclosure include hydrocarbon-based oils containing from 8 to 16 carbon atoms, and especially branched C8-C16 alkanes such as C8-C16 isoalkanes.
- the skin conditioning composition may comprise one or more oils selected from polar emollients selected from esters, triglycerides, ethers, carbonates, alcohols, oils, butters, fatty acids, and their combinations thereof.
- the polar emollients may be selected from those with a molecular weight of 400 g/mol or less.
- the polar emollient may have a molecular weight in the range from about 50 g/mol% to about 350 g/mol.
- the skin conditioning composition may comprise polar emollients that include those derived from C12-C50 fatty acids, preferably C16-C22 saturated fatty acids, and monohydric alcohols.
- esters may be chosen from isopropyl myristate, methyl palmitate, isopropyl laurate, isopropyl palmitate, ethylhexyl palmitate, ethylhexyl laurate, ethylhexyl oleate, ethylhexyl isononanoate, myristyl myristate, 2- ethylhexyl caprate/caprylate (or octyl caprate/caprylate), 2-ethylhexyl palmitate, isostearyl neopentanoate, isononyl isononanoate, hexyl laurate, esters of lactic acid and of fatty alcohols comprising 12 or 13 carbon atoms, dicaprylyl carbonate and their mixtures.
- the one or more oil when present, alone or in combination as a blend of oils, may be present in the skin conditioning composition from about 0.0001% to about 20% or from about 0.001% to about 0.0010%, or from about 0.003% to about 0.004%, or from about 0.01% to about 0.1%, or from about 0.1% to about 10%, or from about 0.5% to about 20%, or from about 1% to about 10%, or from about 5% to about 10%, or from about 2% to about 7%, or from about 0.5% to about 2%, or from about 0.008% to about 0.01%, or from about 0.1% to about 0.2%, or from about 0.5% to about 2%, or from about or any suitable combination, sub- combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- the skin conditioning composition includes more than one oil, each oil present in an amount as set forth herein above, wherein each different oil (such as, for example, plant oils and extracts with oils) may be present within one of the ranges selected from the ranges set forth herein above.
- each of the at least one oil or combination of oils, if present, is present by weight, based on the total weight of the skin conditioning composition, from about 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 to about 20 percent, including increments and ranges therein and there between.
- various non-limiting embodiments of the skin conditioning composition may optionally include at least one surfactant.
- various non-limiting embodiments of the skin conditioning composition that include an oil, for example, but not limited to, a Vitamin E component, such as tocopherol may optionally include at least one surfactant.
- the skin conditioning composition comprises no oil.
- the skin conditioning composition comprises no surfactant.
- the skin conditioning composition comprises at least one oil, for example, tocopherol, with at least one surfactant.
- the skin conditioning composition comprises at least one oil with more than one surfactant.
- the skin conditioning composition comprises at least one oil without any surfactants, wherein the total amount of oil present does not inhibit forming the skin conditioning composition as a clear, single phase solution.
- the at least one surfactant may be an nonionic, cationic, anionic, or a zwitterionic surfactant.
- the at least one surfactant may be selected from the group consisting of polyoxyethylene sorbitan monolaureate, laureth-23, polyoxyethylated octyl phenol, 3-((3- cholamidopropyl) dimethylammonio)-1 propane sulfonate, sodium dilauramidoglutamide lysine, cholate, deoxycholate, sodium dodecylsulfate, TWEEN-80, and combinations thereof.
- the at least one surfactant may exclude esters.
- the at least one surfactant may be present in the skin conditioning composition in a range from about 1% to about 5%, based on the weight of the skin conditioning composition.
- the at least one surfactant when present, comprises one or a combination of polyoxyethylene sorbitan monolaureate and laureth-23.
- the at least one surfactant when present, may be present from about 1% to about 5% by weight of the skin conditioning composition, and in some embodiments, from about 1% to about 2% , and in some embodiments, from about 3% to about 6%, and in some embodiments, from about 3% to about 4.5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- laureth-23 may be present from about 1% to about 5% by weight of the skin conditioning composition, and in some embodiments, from about 3% to about 4.5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- polyoxyethylene sorbitan monolaureate may be present from about 1% to about 5% by weight of the skin conditioning composition, and in some embodiments, from about 1% to about 2%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- the skin conditioning composition comprises more than one surfactant.
- each of the at least one surfactant when present, may be present in a composition according to the disclosure from about 1, 2, 3, 4, to about 5 percent, by weight, including increments and ranges therein and there between.
- Polymeric Thickener In accordance with the disclosure, various non-limiting embodiments of the skin conditioning composition may optionally include one or more polymeric thickeners.
- the one or more thickener may be selected from one or more of natural gums and synthetic polymers, for example, the thickener may be selected from the group consisting of starches (corn, rice, tapioca, potato), gums (xanthan carrageenan, gellan, sclerotium, tarabiotech fermentation).
- the thickener may be selected from acrylates/C10-30 alkyl acrylate crosspolymer, carbomer, xanthan gum, hydroxypropyl guar, ceratonia siliqua (carob) gum, ammonium polyacryloyldimethyl taurate, ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer, and polyacrylate crosspolymer-6.
- the polymeric thickener may be one of carbomer, acrylates/C10-30 alkyl acrylate crosspolymer, polyacrylate crosspolymer-6, microcrystalline cellulose (and) cellulose gum, xanthan gum, sodium carboxymethyl starch, sclerotium gum (and) xanthan gum, xanthan gum (and) ceratonia siliqua (carob) gum (50/50), dehydroxanthan gum, hydroxypropyl starch phosphate, sclerotium gum (and) xanthan gum (75/25), sclerotium gum, xanthan gum (and) sclerotium gum (and) Lecithin (and) pullulan, or combinations thereof.
- the skin conditioning composition may comprise two or more polymeric thickeners.
- the amount of each of the at least one polymeric thickener, when present, may be present in the skin conditioning composition in a range of from about 0.01% to about 2%, or from about 0.01% to about 1.5%, or from about 0.3% to about 1.2%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- One of ordinary skill in the art will appreciate that other ranges are within the scope of the invention.
- the total amount of polymeric thickener in the skin conditioning composition when present, is present from about 0.01% to about 5%, or from about 0.02% to about 2%, or from about 0.03% to about 1.5%, or from about 0.1% to about 0.2%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- any suitable combination, sub-combination, range, or sub-range thereof by weight is present from about 0.01% to about 5%, or from about 0.02% to about 2%, or from about 0.03% to about 1.5%, or from about 0.1% to about 0.2%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- one or more polymeric thickener when present, is present by weight, based on the total weight of the skin conditioning composition, from about 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.5, 4.0, 4.5 to about 5.0 percent, including increments and ranges therein and there between.
- the skin conditioning composition may optionally include one or more preservatives and/or antimicrobials.
- Any preservative commonly used in cosmetic formulations is an acceptable preservative for the skin conditioning compositions herein, such as phenoxyethanol, salicylic acid, members from the paraben family such as the methyl, ethyl, propyl, butyl or isobutyl parabens, 4-hydroxy benzoic acid, benzoic acid, sorbic acid, dehydroacetic acid, triclosan, benzyl alcohol, chlorophenesin, or for example.
- the preservative may comprise one or more of preservatives selected from the group consisting of organic acids, parabens, formaldehyde donors, phenol derivatives, quaternary ammoniums, alcohols, isothiazolinones, and combinations thereof.
- Preservatives having antibacterial activity are optionally present in the skin conditioning compositions of the present invention.
- organic acid preservatives include, but are not limited to, sodium benzoate, potassium sorbate, benzoic acid and dehydroacetic acid, sorbic acid, and combinations thereof.
- a preferred organic acid preservative system includes a mixture of sodium benzoate and potassium sorbate.
- paraben preservatives include, but are not limited to, alkyl para-hydroxybenzoates, wherein the alkyl radical has from 1, 2, 3, 4, 5 or 6 carbon atoms and for example, from 1 to 4 carbon atoms e.g., methyl para- hydroxybenzoate (methylparaben), ethyl para-hydroxybenzoate (ethylparaben), propyl para- hydroxybenzoate (propylparaben), butyl para-hydroxybenzoate (butylparaben) and isobutyl para-hydroxybenzoate (isobutylparaben).
- alkyl para-hydroxybenzoates wherein the alkyl radical has from 1, 2, 3, 4, 5 or 6 carbon atoms and for example, from 1 to 4 carbon atoms e.g., methyl para- hydroxybenzoate (methylparaben), ethyl para-hydroxybenzoate (ethylparaben), propyl para- hydroxybenzoate (propylpara
- formaldehyde donor preservatives include, but are not limited to, 1,3-Dimethylol-5,5-dimethylhydantoin (DMDM hydantoin), imidazolidinyl urea, gluteraldehyde, and combinations thereof.
- quaternary ammonium preservatives include, but are not limited to, benzalkonium chloride, methene ammonium chloride, benzethonium chloride, and combinations thereof.
- alcohol preservatives include, but are not limited to, ethanol, benzyl alcohol, dichlorobenzyl alcohol, phenoxyethanol, and combinations thereof.
- isothiazolone preservatives include, but are not limited to, methylchloroisothiazolinone, methylisothiazolinone, and combinations thereof.
- Other suitable preservatives include, but are not limited to, chloroacetamide, triclosan and iodopropynyl butylcarbamate, pyridine derivatives (e.g., pyrithione and zinc pyrithione), chlorphenesin, phenyl mercuric salts, phenoxyethanol, and other known preservative systems.
- the preservative includes one or more preservatives, the one or combination present at a concentration, by weight of about 0.001% to about 5%, or alternatively about 0.05% to about 2.5% or alternatively about 0.1% to about 2.0%, based upon weight of the skin conditioning composition.
- any one of or a combination of preservatives, when present, may be present, by weight, based on the total weight of the skin conditioning composition, is from about 0.001, 0.002, 0.003 ,0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03 ,0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, to about 5 weight percent, including increments and ranges therein and there between.
- various non-limiting embodiments of the skin conditioning composition may optionally include one or more other additives or actives(optional components), selected from, for example, actives such as acetyl trifluoromethylphenyl valylglycine; a humectant in addition to any glycol, for example caprylyl glycol, squalane, sugars, such as, glucose, xylitol, maltitol, sorbitol, sucrose pentaerythritol, inositol, pyrrolidone carboxylic acid, lactic acid, lithium chloride, acetamide MEA, , dicyanamide, hyaluronic acid, aloe vera, honey, and seaweed extract; preservative and anti-microbial components (such as those listed above), particularly, for example, salicylic acid, and phenoxyethanol; phenolic compounds, such as chalcones, flavones,
- one or more optional components can be present in the skin conditioning composition according to the disclosure from about 0.05% to about 50% by weight, or from about 1% to about 30%, or from about 1.5% to about 20%, and from about 5% to about 15%, or from about 0.05% to about 2.5% by weight, or from about 0.1% to about 2%, or from about 0.25% to about 5%, and from about 0.5% to about 10%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- one or more other components can be present in the skin conditioning composition according to the disclosure from about 0.05 to about 50% by weight, or from about 0.05% to about 25% by weight, or from about 0.1 to about 10%, or from about 0.25% to about 5%, and from about 0.5 to about 3.5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition.
- preservatives may include salicylic acid, and phenoxyethanol.
- one or a combination of optional components may be present, by weight, based on the total weight of the skin conditioning composition, or from about 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 to about 50 weight percent, including increments and ranges therein and there between.
- complementary compositions may include any one or more of the ingredients described herein above, and in some examples specifically as described in the Optional Components.
- Desquamating Agents/Hydroxy Acids [00160]
- the methods of use may include use of a complementary peel composition comprising at least one active ingredient selected from desquamating agents, for example, hydroxy acids.
- desquamating agents for example, hydroxy acids.
- Alpha Hydroxy Acid for example, hydroxy acids.
- the chemical peel component of the skin-enhancing treatment comprises at least one alpha hydroxy acid.
- Suitable alpha hydroxy acids include glycolic acid, lactic acid, tartaric acid, mandelic acid, citric acid, ester derivatives thereof and combinations thereof.
- Exemplary ester derivatives include ester compounds of lactic acid, such as methyl lactate, ethyl lactate, butyl lactate and, similarly, ester compounds of glycolic acid, tartaric acid, mandelic acid, citric acid.
- One particularly suitable alpha hydroxy acid is lactic acid. Lactic acid, or 2-hydroxypropanoic acid, is provided to the chemical peel composition to provide enhanced exfoliation of the skin.
- lactic acid also boosts production of glycosaminoglycan (GAG) in the skin, improving the barrier function and moisturization of skin.
- GAG glycosaminoglycan
- the alpha hydroxy acid in the chemical peel component of the skin-enhancing treatment excludes at least one of lactic acid, glycolic acid, tartaric acid, mandelic acid, and citric acid.
- the chemical peel component of the skin-enhancing treatment includes a concentration of alpha hydroxy acid in a range from about 4% to about 15%, or from about 8% to about 14% or from about 9% to about 13%, or from about 10% to about 12%, or is about 10%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the chemical peel component of the skin-enhancing treatment.
- concentration of alpha hydroxy acid in a range from about 4% to about 15%, or from about 8% to about 14% or from about 9% to about 13%, or from about 10% to about 12%, or is about 10%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the chemical peel component of the skin-enhancing treatment.
- the amount of alpha hydroxy acid present is not more than about 10%.
- any one of or a combination of alpha hydroxy acid is present, by weight, based on the total weight of the chemical peel component of the skin-enhancing treatment, from about 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, to about 15 weight percent, including increments and ranges therein and there between.
- Beta Hydroxy Acid [00168]
- the chemical peel component of the skin-enhancing treatment comprises at least one beta hydroxy acid.
- the chemical peel component of the skin-enhancing treatment includes a beta hydroxy acid comprising salicylic acid.
- beta-hydroxy acid is understood to mean, according to the present invention, a carboxylic acid having a hydroxyl functional group and a carboxylic functional group separated by two carbon atoms.
- a beta hydroxy acid can be present in the chemical peel component of the skin-enhancing treatment in the form of the free acid and/or in the form of one of its associated salts (salts with an organic base or an alkali metal, in particular), especially according to the final pH imposed on the chemical peel component of the skin-enhancing treatment.
- Suitable beta hydroxy acids include salicylic acid and derivatives thereof (including 5- n-octanoylsalicylic acid, salicylate, sodium salicylate, and willow extract), capryloyl salicylic acid, beta hydroxybutanoic acid, propionic acid, beta-hydroxy beata-methylbutyric acid, carnitine tropic acid, and trethocanic acid, and combinations of these.
- the beta hydroxy acid in the chemical peel component of the skin-enhancing treatment excludes at least one of salicylic acid and derivatives thereof (including 5-n-octanoylsalicylic acid, salicylate, sodium salicylate, and willow extract), capryloyl salicylic acid, beta hydroxybutanoic acid, propionic acid, beta-hydroxy beata- methylbutyric acid, carnitine tropic acid, and trethocanic acid.
- salicylic acid and derivatives thereof including 5-n-octanoylsalicylic acid, salicylate, sodium salicylate, and willow extract
- capryloyl salicylic acid including 5-n-octanoylsalicylic acid, salicylate, sodium salicylate, and willow extract
- capryloyl salicylic acid beta hydroxybutanoic acid
- propionic acid beta-hydroxy beata- methylbutyric acid
- carnitine tropic acid carnitine tropic acid
- the chemical peel component of the skin-enhancing treatment includes a concentration of beta hydroxy acid in a range from about 0.1% up to and not more than about 2% of beta hydroxy acid, by weight, based on the total weight of the chemical peel component of the skin-enhancing treatment.
- the chemical peel component of the skin-enhancing treatment includes up to and not more than about 2%, or about 1.9% of beta hydroxy acid.
- the chemical peel component of the skin-enhancing treatment includes up to and not more than about 1% of beta hydroxy acid.
- the amount of beta hydroxy acid present is not more than about 0.40% to about 0.50%.
- the chemical peel component of the skin-enhancing treatment includes from about 0.1% to about 1% of beta hydroxy acid, or from about 0.2% to about 2.0%, or from about 0.1% to about 1.5%, or from about 0.2% to about 1.5%, or from about 0.3% to about 1.0%, or from about 0.35% to about 0.75%, or from about 0.4% to about 0.5%, or is about 0.45%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the chemical peel component of the skin-enhancing treatment.
- beta hydroxy acid or from about 0.2% to about 2.0%, or from about 0.1% to about 1.5%, or from about 0.2% to about 1.5%, or from about 0.3% to about 1.0%, or from about 0.35% to about 0.75%, or from about 0.4% to about 0.5%, or is about 0.45%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the chemical peel component of the skin-enhancing treatment.
- the at least one beta hydroxy acid is present in the chemical peel component of the skin-enhancing treatment from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, to about 2.0 weight percent, including increments and all ranges and subranges therein and there between.
- Phenylethyl Resorcinol may include use of a complementary composition comprising phenylethyl resorcinol.
- Phenylethyl resorcinol functions a tyrosinase inhibitor.
- the phenylethyl resorcinol when utilized in the chemical peel component of the skin-enhancing treatment effectively whiten skin and reduce skin tone unevenness. Phenylethyl resorcinol has not shown adverse effects in basic toxicological tests, including acute oral toxicity, mutagenicity, skin irritation, skin sensitization, and phototoxicity.
- the amount of phenylethyl resorcinol present in the chemical peel component of the skin-enhancing treatment is from about 0.2% to about 2.0%, or from about 0.2% to about 1.5%, or from about 0.4% to about 1.0%, or from about 0.6% to about 0.9%, or from about 0.7% to about 0.8%, or from about 0.2% to about 0.8%, is about 0.75%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the chemical peel component of the skin-enhancing treatment.
- the amount of phenylethyl resorcinol present is not more than about 0.2% to about 0.8%.
- phenylethyl resorcinol when present in the chemical peel component of the skin-enhancing treatment, is present, by weight, based on the total weight of the chemical peel component of the skin-enhancing treatment, from about 0.20, 0.30, 0.40, 0.50, 0.60, 0.70, 0.80, 0.90, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 to about 2.0 weight percent, including increments and ranges therein and there between.
- the skin conditioning composition may be provided in a kit or other article of manufacture.
- the sub compositions that are packaged are maintained as separate until the skin conditioning composition and the at least one complementary composition is intended to be applied to keratinous tissue, at which time they may be separately applied or may be applied together, or may be combined and mixed prior to application.
- the skin conditioning composition is separate from the complementary composition until the skin conditioning composition is intended to be applied to keratinous tissue.
- one sub composition includes at least the hydrogen peroxide and any additional optional oxidizing agent, and one sub composition includes at least the alkaline booster.
- each of the sub compositions may include any one or more of the fatty compounds and any one or more of solvents, surfactants, polymers, actives, and other components.
- any one or more of the fatty compounds and any one or more of solvents, actives and other components may be separately packaged from the other sub compositions, such that the article of manufacture may comprise more than two separate packages or package chambers.
- the article of manufacture may be a packet with separate packages or chambers separated by a frangible seal between the chambers. In use, the seal is broken by the user to contact the separately packaged sub compositions and mix them prior to application onto the skin.
- the article of manufacture may be a tube with dual chambers.
- the article of manufacture may be a dual-chamber pump and the two parts can be mixed in after pumping out of the container.
- the packaging is a single tube with a seal between the two components that is broken to mix.
- the packaging can be a single container holding a suspension of encapsulated material that is mixed/broken to disperse and mix.
- the packaging is otherwise sufficient to retain the skin conditioning composition separate from the complementary composition until the skin conditioning composition is intended to be applied to keratinous tissue.
- the one or both of the first and second parts may be delivered by spray application, or other applicator selected from a pump, or brush.
- a composition of the system for forming a continuous film mask is in a form including a suspension, lotion, cream, serum, essence, gel, stick, spray, ointment, paste, foam, mousse, cream, wipe, patch, strip, film- forming product.
- compositions and systems as described in the representative embodiments herein are selected from commercially available materials, including, as shown in the exemplified embodiments herein below, for example: Urea, glycine, serine, Latic acid, sodium lactate, triacetin, and triethyl citrate.
- Table 2 Raw Materials
- Example 2 Inventive Compositions and Systems
- Five exemplary embodiments of the inventive composition are shown in Table 3.
- Table 3 Inventive Composition
- Example 3 Effect of amino acid on pH
- the effect of amino acid (glycine) on pH was evaluated in compositions with 20% urea and with 40% urea. Stability of pH was not possible at either amount of urea when the amount of amino acid (glycine) was below 5%.
- the pH was stabilized in a range from about 5.5 to about 6.5 above 5% and up to about 9% amino acid (glycine).
- the pH was stable in a range from about 5.5 to about 6.5 but the skin conditioning composition was unstable as evidenced by crystal formation.
- Example 4 Effect of buffer and amino acid (glycine or serine at 5%) on pH and stability
- the effect of buffer on pH and stability was evaluated in compositions with 20% urea and with 40% urea after a period of 4 weeks at 45 o C and at 4 o C.
- the pH remained stable in a range from between 5.5 and 6.5, with overall better performance with buffer (a change of less than 10% over the time period).
- Similar results were obtained with serine, in a higher average range from about 7 to just above pH 7.5.
- Example 5 Effect of 5% Proline vs 3% and 5% Glycine on pH at varying temperatures over time
- the amino acid was substituted to evaluate the effect of % Proline vs 3% and 5% Glycine on pH at varying temperatures over time in (with 40% urea). In all cases the starting pH was about 5.5.
- Example 6 Effect of triacetin
- Triacetin was varied to evaluate its effect on pH and stability. Triacetin was varied at 0.1%, 0.4% and 0.7% and substituted with 1.2% and 2.4% triethyl citrate, and each sample was evaluated at 4 o C, 25 o C, 37 o C and 45 o C. In all examples, the results were comparable, with all samples showing a nominal change in pH at 4 o C , 25 o C and 37 o C, and all samples showing a change of about 10% to about 15% in pH at 45 o C.
- Example 7 Effect of glycols on pH and stability
- the effect of glycols on the pH and stability (from crystallization) of the composition of INV #1 with 40% urea and 5% amino acid (glycine) was varied in glycol content and glycol composition (glycerin and/or propylene glycol).
- Two samples of each formulation were tested, and the formulations included from 0% to 7% glycol (glycerin or propylene glycol), and glycerin:propylene glycol in ratios from 4:1 to 1:4.
- the pH study all samples were maintained for 8 weeks, at 25 o C and 45 o C. In all cases, the pH remained stable in a range from about 5.9 to about 6.9.
- Example 6 Effect of Urea vs hydroxyethyl urea on peel efficacy using a hydroxy acid
- HEU hydroxyethyl urea
- inventive compositions INV #1 (40% urea), INV #1 (a) having 23% urea, INV #1 (b) having 23% HEU, and INV #1 (c) having 40% HEU. Studies were conducted with each of the tested compositions to evaluate effect of the compositions on the stratum corneum.
- DSC differential scanning calorimetry
- each test composition was applied first to skin without rinsing, followed by application of a hydroxy-acid based peel composition in a moisturizer form. The results are shown in FIG 1, FIG 2 and FIG 3.
- the studies revealed that increased amounts of each of urea and hydroxyethyl urea resulted in increased desquamation as compared to use of the peel moisture alone, the desquamation evidenced by stratum corneum disorganization.
- the compositions with urea outperformed those with HEU, and in particular, the 23% urea form performed as well as the 40% HEU form.
- “At least one,” as used herein, means one or more and thus includes individual components as well as mixtures/combinations.
- the transitional terms “comprising”, “consisting essentially of” and “consisting of”, when used in the appended claims, in original and amended form, define the claim scope with respect to what unrecited additional claim elements or steps, if any, are excluded from the scope of the claim(s).
- the term “comprising” is intended to be inclusive or open-ended and does not exclude any additional, unrecited element, method, step or material.
- the term “consisting of” excludes any element, step or material other than those specified in the claim and, in the latter instance, impurities ordinarily associated with the specified material(s).
- weight or amount as used herein with respect to the percent amount of an ingredient refers to the amount of the raw material comprising the ingredient, wherein the raw material may be described herein to comprise less than and up to 100% activity of the ingredient. Therefore, weight percent of an active in a composition is represented as the amount of raw material containing the active that is used, and may or may not reflect the final percentage of the active, wherein the final percentage of the active is dependent on the weight percent of active in the raw material.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
A skin conditioning composition includes a carrier system having a water phase including from about 20% to about 40% urea or a derivative thereof, by weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally: a buffer system having a pH in a range from about 4.0 to about 6.0 and one more additional ingredients, each present in the skin conditioning composition water phase or in a second phase. The skin conditioning composition may have a pH that is less than about 7. A method for improving the efficacy of a skin care active includes applying, in any order, at least skin conditioning composition; and a second composition that includes one or more skin actives not present in the skin conditioning composition. The complementary composition is a leave on or rinse of skin peel composition comprising at least a hydroxy acid. The compositions may be provided as an article of manufacture that includes at least first and second separately contained compositions.
Description
COMPOSITIONS WITH HIGH UREA CONTENT AND METHODS FOR BOOSTING ACTIVES REFERENCE TO RELATED APPLICATIONS AND PRIORITY [0001] This application claims the benefit of, and priority to, US Patent Application No. 63/250,586 filed on September 30, 2021, US Patent Application No. 63/250,577 filed on September 30, 2021, French Application No. FR2113556 filed on December 15, 2021, and French Application No. FR2113553 filed on December 15, 2021, the entireties of which are incorporated herein by reference. FIELD OF TECHNOLOGY [0002] The present disclosure is in the field of cosmetic compositions for topical application to keratinous tissue, particularly compositions that include urea in high amounts, and compositions that include urea in high amounts together with actives for which the urea may provide stabilization and or boosted efficacy. BACKGROUND [0003] Many cosmetic compositions are provided with select actives that provide any number of benefits, for example, including, but not limited to, skin desquamation (peeling). Urea is a commonly used ingredient as a humectant. High concentrations of urea for skin care are desirable for the humectant properties, including as a means to promote the stratum corneum to swell, and for stimulating skin desquamation. Urea is found in many compositions that include other skin actives. Various compositions that may include high concentrations of urea for skin care are thus desirable for the humectant properties. Such skin care compositions would beneficially include urea or a derivative thereof in a range from about 20% to 40% by weight of the composition. However, it is well known that topical preparations that contain high concentrations of urea present many challenges One challenge relates to the tendency of urea to undergo a continuous hydrolysis reaction that leads to pH increase, which can result in an increase from a pH of about 7 up to a pH of 9 or greater over the course of storage. Such pH values at or greater than a pH of 8 are much higher than that of the natural skin, which is about 5.5, and compositions with a pH in this range would likely cause skin irritation when
applied. Thus, such high resultant pH renders most formulations unsuitable for use on skin, particularly in water-based compositions which don’t provide protection through barrier forming oils and butters. This is particularly an issue for water-based leave-on compositions. Yet another challenge is the tendency of urea to crystalize at high concentrations and at low temperature over time. This crystallization would be expected to reduce the amount of active urea available in the usable composition, thus diminishing the overall desired efficacy of the product. A further challenge with high urea content is whitening of the skin which is not aesthetically pleasing to many consumers. [0004] The inventors provide here a cosmetic skin care composition comprising a skin conditioning composition that is used in some embodiments for skin rejuvenation that includes use of the skin conditioning composition followed by use of a secondary complementary composition. In some embodiments the inventors have overcome the foregoing challenges and provide a water-based skin conditioning composition that supports and, in some particular embodiments, boosts the activity of skin actives. In some embodiments the skin conditioning composition is stable from pH increase and crystallization to maintain a high amount of urea for achieving efficacy as a humectant, for promoting the stratum corneum to swell, and for stimulating skin desquamation, among other possible benefits. SUMMARY [0005] This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description of the invention. This summary is not intended to identify key features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter. [0006] In various embodiments, the disclosure provides a cosmetic skin care composition comprising a skin conditioning composition with high urea content in different formats selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover. According to some embodiments, an inventive skin conditioning composition may used alone or as a first step prior to application of a secondary complementary composition comprising one or more actives, such as a hydroxy acid or other water soluble actives.
According to some such embodiments, the inventive composition my boost the efficacy of the active or actives, for example for skin rejuvenation or conditioning. [0007] In accordance with a first embodiment, a skin conditioning composition that includes a carrier system having a water phase, the water phase including urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of the skin conditioning composition is less than about 7. The skin conditioning composition carrier system may also include one more additional ingredients, each present in the water phase or in a second phase. [0008] In various embodiments, the invention provides a skin conditioning composition, comprising: urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of the skin conditioning composition is less than about 7. [0009] In some embodiments, the composition is formulated as a leave-on product. [0010] The skin conditioning composition according to claim 1, wherein the pH is in a range from about 4.0 to about 6.0. [0011] In some embodiments, the at least one amnio acid is soluble in water at a pH from about 4 to about 6. [0012] In some embodiments, the at least one amnio acid is selected from the group consisting of glycine, proline, serine, cysteine and combinations thereof. [0013] In some embodiments, the at least one amnio acid is present in an amount from about 5% to about 9%, by weight, based on the weight of the composition. [0014] In some embodiments, the at least one of triacetin or triethyl citrate is present in an amount from about 0.2% to about 2%%, by weight, based on the weight of the composition. [0015] In some embodiments, the invention provides a skin conditioning composition wherein the at least one amino acid is selected from the group consisting of glycine, proline, serine, cysteine and combinations thereof and is present in an amount from about 5% to about
9%, by weight, based on the weight of the composition; and the at least one of triacetin or triethyl citrate, is present in an amount a range that includes about 0.2% to about 2%, by weight, based on the weight of the composition; and wherein the skin conditioning composition comprises a buffer system comprising one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof, wherein the skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 oC up to 45 oC and through freeze thaw cycles from -20 oC through 20 oC, characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7. [0016] In some embodiments, the skin conditioning composition further comprising at least one pH adjusting reagent comprising triethanolamine. [0017] In some embodiments, the urea or a derivative thereof, is present in an amount from greater than about 20% to about 40%, by weight, based on the weight of the composition, and further comprising at least one glycol selected from the group consisting of propylene glycol, glycerin, and combinations thereof. [0018] In some embodiments, the skin conditioning composition comprises propylene glycol and excludes glycerin. [0019] In some embodiments, the invention provides a skin conditioning composition, comprising: urea present from greater than 20% to about 40%; at least one amino acid, the at least one amino acid comprising glycine present from about 5% to about 9%; at least one of triacetin or triethyl citrate, present from about 0.2% to about 2%; a buffer system having a pH in a range from about 4.0 to about 6.0; at least one pH adjusting reagent, comprising triethanolamine; and at least one glycol selected from the group consisting of propylene glycol, glycerin, and combinations thereof, wherein all amounts are by weight, based on the weight of the composition, and wherein the pH is from about 4.0 to about 6.0, and wherein the skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 oC up to 45 oC and through freeze
thaw cycles from -20 oC through 20 oC, characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7. [0020] In some embodiments, the skin conditioning composition comprises propylene glycol and excludes glycerin. [0021] In some embodiments, the buffer system comprises one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof. [0022] In some embodiments, the buffer system comprises sodium lactate and lactic acid. [0023] In some embodiments, the invention provides a skin conditioning composition, comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of The skin conditioning composition is less than about 7. [0024] In some embodiments, the carrier system further comprises one more additional ingredients, each present in the water phase or in a second phase. [0025] The skin conditioning composition according to claim 17, wherein the second phase is an oily phase. [0026] In some embodiments, the one or more additional ingredients includes one or more of an additional ingredient selected from the group consisting of a skin active compound, a humectant in addition to any glycol, an oil, a surfactant, a thickener, a preservative, and combinations thereof. [0027] In some embodiments, the skin conditioning composition is one of a single phase solution comprising the water phase, a multi-phase solution comprising at least one additional phase, or an emulsion comprising at least one oily phase. [0028] In some embodiments, the skin conditioning composition is a product for keratinous tissue selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover. [0029] In some embodiments, the skin conditioning composition is a leave-on formulation.
[0030] In another aspect, the present disclosure provides a method of contacting a portion of skin with skin conditioning composition with or without an implement or an applicator. The methods may further include application of a complementary composition, before or after application of the skin conditioning composition. [0031] In a second embodiment, provided is a home use skin conditioning composition with high urea content in different formats selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover. The skin conditioning composition is used as first step prior to application of a complementary composition comprising one or more actives, such as a hydroxy acid or other water soluble actives, to boost the efficacy of the active or actives, for example for skin rejuvenation. [0032] In another aspect, provided are methods of use of the skin conditioning composition. In some embodiments, a method of use includes application of the skin conditioning composition as a leave on for providing moisture retention benefits. In some embodiments, a method of use includes application of the skin conditioning composition as a leave on, followed by application, of a complementary composition, such as, but not limited to, a complementary composition containing one or more actives that can complement or supplement the benefits of the skin conditioning composition. [0033] In another aspect, the disclosure provides a system (or kit) employing the skin conditioning composition and one or more complementary compositions comprising one or more actives, such as a hydroxy acid or other water soluble actives. In some embodiments, the disclosure provides a regimen employing the skin conditioning composition. [0034] In various embodiments of use of the skin conditioning composition and system, the regimen includes application, in one, two, three or more application steps of a first composition comprising at least one of the skin conditioning composition and a complementary composition, and a second composition comprising at least one of the skin conditioning composition and a complementary composition. In some embodiments, the first and second compositions are different. In some embodiments, the first and second compositions are the same. Accordingly, in some embodiments, the first composition comprises the skin conditioning composition, and the second composition comprises the complementary
composition. And in other embodiments, the first composition comprises the complementary composition, and the second composition comprises the skin conditioning composition. Application may include three or more sequential steps where first and second compositions are applied in any order. [0035] In some embodiments after application of the complementary composition, both compositions are either left on the skin or may be removed by rinsing. In some embodiments, the application of one or both may include use of an implement such as a brush. [0036] In another aspect, the present disclosure provides a method of contacting a portion of skin with skin conditioning composition with or without an implement or an applicator. The methods may further include application of a complementary composition, before or after application of the skin conditioning composition. [0037] In some particular embodiments, provided is a method improving the efficacy of a skin care active, comprising: a) applying to a region of skin a first composition comprising a skin conditioning composition comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH is less than about 7; b) applying to the region of skin a second composition comprising complementary composition comprising one or more skin actives not present in the skin conditioning composition. [0038] In accordance with some embodiments, the steps of the method include (a) and (b) in any order. [0039] In accordance with some embodiments, each of the compositions is aqueous and is applied in liquid form. [0040] In accordance with some embodiments, the first composition is one of a water- based toner or a mask. [0041] In accordance with some embodiments, the first composition is a water-based toner that is applied first followed by the second composition without prior removal of the first composition.
[0042] In accordance with some embodiments, the first composition is a water-based mask that is applied first followed by the second composition, the method further comprising a step that includes rinsing to remove the first composition prior to application of the second composition. [0043] In accordance with some embodiments, one or both of the first and second compositions is coupled to an application surface of an applicator, the application surface selected from the group consisting of a bristle surface of a brush, a roller surface of a rolling applicator, and a blade surface of a spatula [0044] In other embodiments, provided is an article of manufacture for providing a skin system for improving the efficacy of a skin care active, the article of manufacture comprising: at least first and second separately contained compositions. [0045] the first composition comprising a skin conditioning composition comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH is less than about 7, and the second composition comprising a complementary composition comprising one or more skin actives not present in the skin conditioning composition. [0046] In accordance with some embodiments, the first and second compositions are one of (i) contained to be mixable prior to application to skin, and (ii) contained to be applied separately, in any order. [0047] In accordance with any of the foregoing embodiments disclosed herein, one or both compositions may be coupled to an application surface of an applicator. In accordance with any of the embodiments disclosed herein, the application surface may be a surface of a mask configured to conform to a face of a wearer. In accordance with any of the embodiments disclosed herein, the application surface may be selected from the group consisting of a bristle surface of a brush, a roller surface of a rolling applicator, and a blade surface of a spatula. In accordance with any of the embodiments disclosed herein, the skincare formulation may be disposed in a first compartment of a sachet and the application surface may be a surface of a
second compartment of the sachet, and wherein the first compartment and the second compartment are fluidically separated by a breakable barrier. [0048] Other features and advantages of the present invention will be apparent from the following more detailed description, taken in conjunction with the accompanying drawings which illustrate, by way of example, the principles of the invention. [0049] The detailed description set forth below in connection with the appended drawings, where like numerals reference like elements, is intended as a description of various embodiments of the disclosed subject matter and is not intended to represent the only embodiments. The embodiments described in this disclosure are provided merely as examples or illustrations and should not be construed as preferred or advantageous over other embodiments. The illustrative examples provided herein are not intended to be exhaustive or to limit the claimed subject matter to the exact forms disclosed. [0050] This disclosure describes exemplary embodiments in accordance with the general inventive concepts and is not intended to limit the scope of the invention in any way. Indeed, the invention as described in the specification is broader than and unlimited by the exemplary embodiments set forth herein, and the terms used herein have their full ordinary meaning. BRIEF DESCRIPTION OF THE DRAWINGS
[0051] FIG. 1 is a bar graph that shows stratum corneum test results demonstrating the comparative efficacy of the inventive composition used according to the inventive methods as compared with controls. [0052] FIG. 2 is a bar graph that shows stratum corneum test results demonstrating the comparative efficacy of the inventive composition at different concentrations of urea and used according to the inventive methods as compared with controls. [0053] FIG. 3 is a bar graph that shows stratum corneum test results demonstrating the comparative efficacy of the inventive composition employing different forms of urea and used according to the inventive methods as compared with controls. [0054] Aspects and many of the attendant advantages of the claimed subject matter will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings. [0055] The detailed description set forth below in connection with the appended drawings, where like numerals reference like elements, is intended as a description of various embodiments of the disclosed subject matter and is not intended to represent the only embodiments. The embodiments described in this disclosure are provided merely as examples or illustrations and should not be construed as preferred or advantageous over other embodiments. The illustrative examples provided herein are not intended to be exhaustive or to limit the claimed subject matter to the exact forms disclosed. DETAILED DESCRIPTION [0056] The skin conditioning composition of the present invention may be used for the production of cosmetic preparations, or dermatological preparations, more particularly topical treatment preparations, that may be formulated as single-phase water-based solution compositions, cosmetic serums, or aerosols, for example. Topical application to a surface may be a surface such as the mucus membrane or the skin, for example. [0057] In various embodiments, the disclosure provides a cosmetic skin care composition comprising a skin conditioning composition with high urea content in different formats selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover. According to some embodiments, an inventive skin conditioning composition may
used alone or as a first step prior to application of a secondary complementary composition comprising one or more actives, such as a hydroxy acid or other water soluble actives. According to some such embodiments, the inventive composition my boost the efficacy of the active or actives, for example for skin rejuvenation or conditioning. [0058] As used herein, the terms “skin conditioning” and “skin rejuvenation” in reference to the inventive skin conditioning composition means acting as a humectant as a means to promote the stratum corneum to swell, and for stimulating skin desquamation. In some embodiments, including as exemplified herein, the skin conditioning composition is especially useful according to methods for rejuvenation including application of the skin conditioning composition to promote the stratum corneum of skin to swell to thereby stimulate the skin to be responsive to a secondary treatment. [0059] “Cosmetically acceptable” means compatible with any keratinous substrate. For example, “cosmetically acceptable carrier” means a carrier that is compatible with any keratinous substrate. [0060] The term “stable” as used in reference to the structural or solubility state of the ingredients of the skin conditioning composition means that the skin conditioning composition lacks crystal formation that is visible to the naked eye, and does not demonstrate visually perceptible crystal formation over a period of time, for example for one, two or four or five days, or for a period of one or more weeks, and for example up to eight (8) weeks, and wherein when crystals are visualized at a temperature at or below 4 °C, such crystals disappear with or without mild agitation within 24 hours of reaching an ambient temperature from about 25 °C up to about 37 °C and after freeze thaw cycles from -20 oC through 20 oC. The term “stable” as used in reference to the pH the skin conditioning composition means that the pH does not increase appreciably over time, for example as described in the examples herein. [0061] The term “leave-on” as used herein refers to a composition which is applied and is not removed by wiping or rinsing with water. [0062] In some embodiments, the disclosure provides a home use skin conditioning composition with high urea content in different formats selected from a water toner, a gel, a mask, a micellar water, a cream, a lotion, a cleanser, or a make-up remover. The skin
conditioning composition is used as first step prior to application of a complementary composition comprising one or more actives, such as a hydroxy acid or other water soluble actives, to boost the efficacy of the active or actives, for example for skin rejuvenation. [0063] Applicants have unexpectedly found that use of a skin rejuvenation or skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 oC up to 45 oC and through freeze thaw cycles from -20 oC through 20 oC. The stabilities are characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7, and in some particular embodiments that include greater than 20% and up to at least 40% urea. In some embodiments, the composition can surprisingly improve the efficacy of a second complimentary composition that includes at least one skin active. These benefits are accomplished wherein the skin conditioning composition stabilities are characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7, in particular in embodiments that include greater than 20% and up to at least 40% urea. Examples provided herein demonstrate these and other aspects of the unexpected properties of the skin conditioning composition. [0064] In accordance with the disclosure, the invention also provides methods of use of the skin conditioning composition for rejuvenation of the skin. In some embodiments, a method of use includes application of the skin conditioning composition as a leave on for providing moisture retention benefits. In some embodiments, a method of use includes application of the skin conditioning composition as a leave on, followed by application, of a complementary composition, such as, but not limited to, a complementary composition containing one or more actives that can complement or supplement the benefits of the skin conditioning composition. [0065] In some embodiments, the disclosure provides a system (or kit) employing the skin conditioning composition and one or more complementary compositions comprising one or more actives, such as a hydroxy acid or other water soluble actives. In some embodiments, the disclosure provides a regimen employing the skin conditioning composition. [0066] In various embodiments of use of the skin conditioning composition and system, the regimen includes application, in one, two, three or more application steps of a first composition
comprising at least one of the skin conditioning composition and a complementary composition, and a second composition comprising at least one of the skin conditioning composition and a complementary composition. In some embodiments, the first and second compositions are different. In some embodiments, the first and second compositions are the same. Accordingly, in some embodiments, the first composition comprises the skin conditioning composition, and the second composition comprises the complementary composition. And in other embodiments, the first composition comprises the complementary composition, and the second composition comprises the skin conditioning composition. Application may include three or more sequential steps where first and second compositions are applied in any order. [0067] In some embodiments after application of the complementary composition, both compositions are either left on the skin or may be removed by rinsing. In some embodiments, the application of one or both may include use of an implement such as a brush. [0068] Skin conditioning composition [0069] In various embodiments, the skin conditioning composition is formed by providing the carrier system having a water-phase that comprises water. In various embodiments, the carrier system may further comprise one more additional ingredients, each present in the water phase or in another phase, such as an oily phase. In various embodiments, the one or more additional ingredients includes one or more of an additional ingredient selected from the group consisting of a skin active compound, humectant in addition to any glycol, a preservative, a surfactant, a thickener, and combinations thereof. In some embodiments, the skin conditioning composition may include one or more of any one of the additional ingredients. In some embodiments, the skin conditioning composition may also include fragrances, pH adjusters, other cosmetically acceptable additives, or a combination thereof. [0070] The skin conditioning composition may be any suitable form, such as, but not limited to, a single phase solution comprising the water phase, a multi-phase solution comprising at least one water phase, an emulsion comprising a water phase and an oily phase, such as, but not limited to, a water-in-oil emulsion, an oil-in-water emulsion, or a silicone-in-water
emulsion. The skin conditioning composition may be provided in a product form for application to keratinous tissue, such as, but not limited to, a skin care product or a hair care product, and may be a product form such as, but not limited to, a micellar water, a cream or lotion, a toner, a cleanser, or a make-up remover. The skin conditioning composition in any of the product forms may be either a leave-on or a rinse-off formulation. In certain embodiments, as exemplified herein, the skin conditioning composition is a leave-on formulation. [0071] As further described herein below, the skin conditioning composition includes a carrier system having a water phase, the water phase including urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of the skin conditioning composition is less than about 7. The skin conditioning composition carrier system may also include one more additional ingredients, each present in the water phase or in a second phase. [0072] Urea [0073] In accordance with the various embodiments, the skin conditioning composition includes urea present in an amount sufficient to enhance penetration of the active ingredient(s). [0074] In some embodiments, urea may be provided as one of urea, or a urea derivative, for example, hydroxyethyl urea (HEU), wherein urea has a formula (I) and HEU has a formula (II) as shown below.
[0075] Molecular weight information for each of these is shown in Table 1. [0076] Table 1
[0077] Generally, a urea or a derivative thereof is selected for its beneficial effects to the skin, which effect is to be enhanced by exposure to urea of the viable epidermis and/or dermis, which underlies the stratum corneum, wherein a urea derivative can be described by the general formula (III): R1R2N—C(═O)—NR3R4 (III) wherein R1, R2, R3 and R4 each represent, independently of each other, a hydrogen atom, a C1-C4 alkyl group or a C2-C6 hydroxyalkyl group which optionally contains from 1 to 5 hydroxyl groups, where at least one of the radicals R1 to R4 represents a hydroxyalkyl group, and their salts, their solvates and their isomers in a composition containing a physiologically acceptable medium, as agent intended for stimulating desquamation of the skin and/or the mucous membranes and/or the superficial body growths. As described in United States Patent US7999008, such urea derivatives have a remarkable effect on several mechanisms involved in desquamation, thus allowing a complete and natural action of stimulating this process, and the application in all cases where it is desirable to promote and/or accelerate the removal of the dead layers of the epidermis. For compounds of formula (III):
[0078] Preferably, R, denotes a C2-C6 hydroxyl group, and R2, R3 and R4 denote, independently of each other, a hydrogen atom or a C1-C4 alkyl group. [0079] Preferably, R1 denotes a C2-C6 hydroxyalkyl group comprising from 1 to 5 hydroxyl groups, in particular 1 hydroxyl group, and R2, R3 and R4 denote a hydrogen atom. [0080] More preferably, R1 denotes a C2-C4 hydroxyalkyl group comprising 1 hydroxyl group, and R2, R3 and R4 denote a hydrogen atom. [0081] Among the alkyl groups, there may be mentioned in particular methyl, ethyl, n- propyl, isopropyl, n-butyl, isobutyl and tert-butyl groups. [0082] Among the hydroxyalkyl groups, those containing a single hydroxyl group are preferred, and in particular the hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl and hydroxyhexyl groups, are preferred. [0083] Among the salts, there may be mentioned in particular the salts of inorganic acids, such as sulphuric acid, hydrochloric acid, hydrobromic acid, hydriodic acid, phosphoric acid and boric acid. There may also be mentioned the salts of organic acids, which may contain one or more carboxylic, sulphonic or phosphonic acid groups. They may be linear, branched or cyclic aliphatic acids or aromatic acids. These acids may additionally contain one or more heteroatoms chosen from O and N, for example in the form of hydroxyl groups. There may be mentioned in particular propionic acid, acetic acid, terephthalic acid, citric acid and tartaric acid. [0084] The expression solvate is understood to mean a stoichiometric mixture of the said compound of formula (III) with one or more molecules of water or of organic solvent, such a mixture typically being obtained from the synthesis of the compound of formula (III). [0085] Embodiments of formula (III), there may be mentioned N-(2-hydroxyethyl)urea; N- (2-hydroxypropyl)-urea; N-(3-hydroxypropyl)urea; N-(2,3-dihydroxypropyl)-urea; N-(2,3,4,5,6- pentahydroxyhexyl)urea; N-methyl-N-(1,3,4,5,6-pentahydroxy-2-hexyl)urea; N-methyl-N′-(1- hydroxy-2-methyl-2-propyl)urea; N-(1-hydroxy-2-methyl-2-propyl)urea; N-(1,3-dihydroxy-2- propyl)urea; N-(tris-hydroxymethylmethyl)urea; N-ethyl-N′-(2-hydroxyethyl)urea; N,N-bis(2- hydroxyethyl)urea; N,N′-bis(2-hydroxyethyl)urea; N,N-bis(2-hydroxypropyl)urea; N,N′-bis(2- hydroxypropyl)urea; N,N-bis(2-hydroxyethyl)-N′-propylurea; N,N-bis(2-hydroxypropyl)-N′-(2-
hydroxy-ethyl)urea; N-tert-butyl-N′-(2-hydroxyethyl)-N′-(2-hydroxypropyl)urea; N-(1,3- dihydroxy-2-propyl)-N′-(2-hydroxyethyl)urea; N,N-bis(2-hydroxyethyl)-N′,N′-dimethylurea; N,N,N′,N′-tetrakis(2-hydroxyethyl)urea; N′,N′-bis(2-hydroxyethyl)-N′,N′-bis(2-hydroxypropyl)- urea; salts and solvates thereof, and mixtures thereof. [0086] In accordance with the various embodiments total amount of the urea or derivative thereof is in a range from about 20% to about 40%, or from about 20% to about 35%, or from about 25% to about 30%, or from about 25% to about 40%, or from about 30% to about 35% or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. [0087] Thus, the urea or derivative thereof, is present, by weight, based on the total weight of the composition, from about 20, 21, 22, 23, 24, 25,26,27,28, 29, 30, 31,32, 33, 34, 35,36,37, 38, 39 to about 40 weight percent, including increments and ranges therein and there between. [0088] Amino Acid [0089] In accordance with the various embodiments, the skin conditioning composition includes at least one or more amino acids. In some embodiments the at least one amino acid may be selected from the group consisting of naturally occurring amino acids. In some embodiments the at least one amino acid may be selected from glycine, proline, serine and cysteine. And in some embodiments the at least one amino acid comprises glycine. [0090] As non-limiting examples, the amino acids that may be used may be of natural or synthetic origin, in L, D, or racemic form, and comprise at least one acid function chosen from, for instance, carboxylic acid, sulfonic acid, phosphonic acid, and phosphoric acid functions. The amino acids may be in their neutral or ionic form. Polymeric forms are also useful, such as poly arginine, poly lysine, etc. Additional non-limiting examples include basic amino acids comprising an additional amine function optionally included in a ring or in a ureido function. In some cases, amino acids that may be used include, but are not limited to, aspartic acid, glutamic acid, alanine, arginine, ornithine, citrulline, asparagine, carnitine, cysteine, glutamine, glycine, histidine, lysine, isoleucine, leucine, methionine, N-phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine, ornithine, citrulline, and valine.
[0091] In accordance with the various embodiments, the amount of amnio acid present in a composition according to the disclosure can range from about 2% to about 10%, or from about 3% to about 9%, or from about 4% to about 8%, or from about 3% to about 5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the composition. In some embodiments according to the disclosure, the composition includes at least about 3%, or at least about 5% of the at least one amino acid. In some embodiments according to the disclosure, the composition includes not more than about 9% of the at least one amino acid. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. In some embodiments, two or more alkaline boosters are present. [0092] Thus, any one of or a combination of the amino acid may be present, by weight, based on the total weight of the composition, or from about 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5 to about 10.0 weight percent, including increments and ranges therein and there between. [0093] Triacetin/Triethyl Citrate [0094] In accordance with the various embodiments, the skin conditioning composition includes at least one or more of triacetin or triethyl citrate. [0095] In accordance with the various embodiments, the amount of triacetin or triethyl citrate present in a composition according to the disclosure can range from about 0.2% to about 2%, or from about 0.3% to about 1.5%, or from about 0.5% to about 1.2%, or from about 0.7% to about 1%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. In some embodiments according to the disclosure, the skin conditioning composition includes at least about 0.2%, or at least about 0.7% of the triacetin or triethyl citrate. In some embodiments according to the disclosure, the skin conditioning composition includes not more than about 1% of the triacetin or triethyl citrate. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. In some embodiments, two or more alkaline boosters are present.
[0096] Thus, any one of or a combination of the triacetin or triethyl citrate may be present, by weight, based on the total weight of the skin conditioning composition, or from about 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, to about 2 weight percent, including increments and ranges therein and there between. [0097] Buffer System [0098] In accordance with some embodiments, the skin conditioning composition may include a buffer system. In some embodiments, the buffer system comprises one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof. In some particular embodiments, the buffer system comprises sodium lactate, lactic acid, ammonium lactate, and combinations thereof. In some particular embodiments, the buffer system comprises citric acid, sodium citrate, and combinations thereof. [0099] More generally, the buffer system is selected from conventional buffer systems commonly used for compositions used on keratinous tissue, particularly skin. Buffer systems may include one or a combination of acidifying agents and alkalifying agents. Acidifying agents include, for example, organic or inorganic acids such as hydrochloric acid, orthophosphoric acid, sulphuric acid, carboxylic acids such as acetic acid, tartaric acid, citric acid and lactic acid, and sulphonic acids. Alkalifying agents include, for example, aqueous ammonia, alkali metal carbonates, alkanolamines such as mono-, di- and triethanolamines and their derivatives, sodium hydroxide or potassium hydroxide. [00100] In accordance with the various embodiments, the amount of buffer components, when present in a skin conditioning composition according to the disclosure, generally conform to those employed conventionally. According to the disclosure, a buffer system comprising, for example, sodium lactate, lactic acid, ammonium lactate, and combinations thereof, includes each of the buffer system components present in a range from about 0.1% to about 3%, or from about 0.25% to about 2.5%, or from a total of about 0.1% to about 6%, or from about 0.25% to about 5.25%, or any suitable combination, sub-combination, range, or sub- range thereof by weight, based on the weight of the skin conditioning composition. More generally, in some embodiments according to the disclosure, the skin conditioning composition
includes each one or more buffer components present in a range from about 0.1% to about 15%. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. In some embodiments, two or more alkaline boosters are present. [00101] Thus, any one of or a combination of buffer system components may be present, by weight, based on the total weight of the skin conditioning composition, or from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,12, 13, 14, to about 15 weight percent, including increments and ranges therein and there between. [00102] Glycol [00103] In accordance with the various embodiments, the skin conditioning composition may include at least one alkanol, and particularly at least one glycol. In some embodiments, the skin conditioning comprises one or a combination of alkanols (polyhydric alcohols such as glycols and polyols). In some embodiments, the skin conditioning comprises one or a combination of propylene glycol, glycerin, propanediol, butylene glycol, dipropylene glycol, pentylene glycol, hexylene glycol, ethoxydiglycol, and combinations thereof. In some particular embodiments, the skin conditioning may comprise at least propylene glycol, with or without glycerin. [00104] More generally, the skin conditioning may comprise one or a combination of the 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, diethylene glycol, butylene glycol, hexylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 1,3-butanediol, 2,3-butanediol, 1,4-butanediol, 3-methyl-1,3-butanediol, 1,5- pentanediol, tetraethylene glycol, 1,6-hexanediol, 2-methyl-2,4-pentanediol, polyethylene glycol, 1,2,4-butanetriol, 1,2,6-hexanetriol, 2-butene-1,4-diol, 2-ethyl-1,3-hexanediol, 2-methyl- 2,4-pentanediol, (caprylyl glycol), 1,2-hexanediol, 1,2-pentanediol, and 4-methyl-1,2- pentanediol; alkyl alcohols having 1 to 4 carbon atoms such as ethanol, methanol, butanol, propanol, and isopropanol; glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-propyl ether, ethylene glycol mono-iso-propyl ether, diethylene glycol mono-iso-
propyl ether, ethylene glycol mono-n-butyl ether, ethylene glycol mono-t-butyl ether, diethylene glycol mono-t-butyl ether, 1-methyl-1-methoxybutanol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-t-butyl ether, propylene glycol mono-n-propyl ether, propylene glycol mono-iso-propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol mono-n- propyl ether, and dipropylene glycol mono-iso-propyl ether; 2-pyrrolidone, N-methyl-2- pyrrolidone, 1,3-dimethyl-2-imidazolidinone, formamide, acetamide, dimethyl sulfoxide, sorbit, sorbitan, acetine, diacetine, triacetine, sulfolane, or mixtures thereof. [00105] In accordance with the various embodiments, the amount of the at least one glycol present in the skin conditioning composition can range from about 1% to about 15%, or from about 2% to about 12%, or from about 3% to about 10%, or from about 3.5% to about 5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. [00106] Thus, any one of or a combination of glycol, when present, may be present, by weight, based on the total weight of the skin conditioning composition, is from about 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10, 10.5, 11, 11.5, 12, 12.513, 13.5, 14, 14.5, to about 15 percent, by weight, based on the weight of the skin conditioning composition, including increments and ranges therein and there between. [00107] Carrier system [00108] In various embodiments, the skin conditioning composition is formed by providing a carrier system having a water-phase that comprises water. The urea, amino acid, triacetin/Triethyl citrate, and buffer system components are typically preferentially in the water phase. As described herein below, the skin conditioning composition may include other ingredients, and the carrier system may include other phases, including one or more additional water and/or oil phases. [00109] Water Phase/Water
[00110] In various embodiments, the skin condition composition includes at least one water phase that includes water. [00111] The skin conditioning composition comprises from about 40% to about 70% by weight of water, with respect to the total weight of the skin conditioning composition. In some embodiments, the amount of water in the skin conditioning composition can range from about 40% to about 70%, or from about 45% to about 65%, or from about 50% to about 60%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. [00112] The pH of the skin conditioning composition is in the range from and including about 4 to about 6, and in some embodiments is one of between 5.5 and 6.5, or between 4 and 5, or between 5 and 6, or up to about 7. The pH can be adjusted to the desired value by addition of a base (organic or inorganic) to the skin conditioning composition, for example ammonia or a primary, secondary or tertiary (poly)amine, such as monoethanolamine, diethanolamine, triethanolamine, isopropanolamine or 1,3-propanediamine, or alternatively by addition of an inorganic or organic acid, for example a carboxylic acid, such as, for example, citric acid. [00113] Thus, water may be present by weight, based on the total weight of the skin conditioning composition, or from about 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, to about 70 weight percent, including increments and ranges therein and there between. [00114] Optional Components [00115] Cosmetic Oils/Emollients [00116] In accordance with some embodiments, the skin conditioning composition may comprise at least one oily phase which may include any one or a combination of cosmetic oils. In some embodiments, the oil is generally immiscible in water. The oil may be selected from hydrocarbons, silicones, fatty alcohols, glycols, and vegetable oils. The oil may include one or a combination of polar and non-polar oil. In some embodiments, the oil may be chosen from hydrocarbon-based oils from plants or of plant origin, mineral oil, ester oils, fatty alcohols containing from 12 to 26 carbon atoms, fatty acids containing from 12 to 26 carbon atoms and vinylpyrrolidone copolymers, and combinations thereof.
[00117] In some particular embodiments, the oil may be selected from the group consisting of, coco-caprylate/caprate, dicaprylyl carbonate, dicaprylyl ether, isopropyl palmitate, and combinations thereof. [00118] The term "silicone oil" relates to oil comprising at least one silicon atom, and especially at least one Si-O group. The term "fluoro oil" relates to oil comprising at least one fluorine atom. The term "hydrocarbon-based oil" relates to oil comprising mainly hydrogen and carbon atoms. Hydrocarbon-based oil may be animal hydrocarbon-based oil, plant hydrocarbon-based oil, mineral hydrocarbon-based oil, or a synthetic hydrocarbon-based oil. Further, suitable oil may be a mineral hydrocarbon-based oil, a plant hydrocarbon-based oil, or a synthetic hydrocarbon-based oil. [00119] Silicone Oils [00120] The skin conditioning composition may comprise one or more silicone oils. Non- limiting examples of silicone oils include dimethicone, cyclomethicone, polysilicone-11, phenyl trimethicone, trimethylsilylamodimethicone, and stearoxytrimethylsilane. In some cases, the skin conditioning composition includes dimethicone, and optionally additional oils, including additional silicone oils. Typically, the one or more silicone oils is a non-volatile silicon oil. In some embodiments, the silicone oil is polydimethylsiloxanes (PDMSs), polydimethylsiloxanes comprising alkyl or alkoxy groups which are pendent and/or at the end of the silicone chain, which groups each contain from 2 to 24 carbon atoms, or phenyl silicones, such as phenyl trimethicones, phenyl dimethicones, phenyl(trimethylsiloxy)diphenylsiloxanes, diphenyl dimethicones, diphenyl(methyldiphenyl)trisiloxanes or (2-phenylethyl)trimethylsiloxysilicates. [00121] Other examples of silicone oils that may be mentioned include volatile linear or cyclic silicone oils, especially those with a viscosity 8 centistokes (8x106 m2/s) and especially containing from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups containing from 1 to 10 carbon atoms. As volatile silicone oils that may be used in the invention, mention may be made especially of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethylhexyltrisiloxane, heptamethyloctyltrisiloxane, hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane and dodecamethylpentasiloxane, and mixtures thereof.
[00122] Fluoro Oils [00123] The skin conditioning composition may comprise one or more fluoro oils. For example, the one or more fluoro oil may be selected from the group consisting of perfluoromethylcyclopentane, perfluoro-1,3-dimethylcyclohexane, dodecafluoropentane, tetradecafluorohexane, bromoperfluorooctyl, nonafluoromethoxybutane, nonafluoroethoxyisobutane and 4-trifluoromethylperfluoromorpholine. Volatile fluoro oils, such as nonafluoromethoxybutane, decafluoropentane, tetradecafluorohexane, dodecafluoropentane, may also be used. [00124] Hydrocarbon-Based Oils [00125] The skin conditioning composition may comprise one or more hydrocarbon-based oils. For example, the hydrocarbon-based oil may be a saturated hydrocarbon, an unsaturated hydrocarbon, lipids, triglycerides, a natural oil, and/or a synthetic oil. In some embodiments, the skin conditioning composition may include a synthetic oil selected from the group consisting of hydrogenated polyisobutene and hydrogenated polydecene. A hydrocarbon- based oil may be a non-volatile hydrocarbon-based, such as: (i) hydrocarbon-based oils of plant origin, such as glyceride triesters, which are generally triesters of fatty acids and of glycerol, the fatty acids of which can have varied chain lengths from C4 to C24, it being possible for these chains to be saturated or unsaturated and linear or branched; these oils are in particular wheat germ oil, sunflower oil, grape seed oil, sesame oil, corn oil, apricot oil, castor oil, shea oil, avocado oil, olive oil, soybean oil, sweet almond oil, palm oil, rapeseed oil, cottonseed oil, hazelnut oil, macadamia oil, jojoba oil, alfalfa oil, poppy oil, pumpkin seed oil, marrow oil, blackcurrant oil, evening primrose oil, millet oil, barley oil, quinoa oil, rye oil, safflower oil, candlenut oil, passionflower oil, and musk rose oil; (ii) synthetic ethers containing from 10 to 40 carbon atoms; (iii) linear or branched hydrocarbons of mineral or synthetic origin, such as petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam, and 40 squalane; (iv) synthetic esters, for instance oils of formula RCOOR' in which R represents a linear or branched fatty acid residue containing from 1 to 40 carbon atoms and R' represents a
hydrocarbon-based chain that is especially branched, containing from 1 to 40 carbon atoms on condition that R+R' is ÿ 10, for instance Purcellin oil (cetearyl octanoate), isopropyl myristate, isopropyl palmitate, C12-C15 alkyl benzoate, such as the product sold under the trade name Finsolv TN® or Witconol TN® by Witco or Tegosoft TN® by Evonik Goldschmidt, 2-ethylphenyl benzoate, such as the commercial product sold under the name X-Tend 226 by ISP, isopropyl lanolate, hexyl laurate, diisopropyl adipate, isononyl isononanoate, oleyl erucate, 2-ethylhexyl palmitate, isostearyl isostearate, diisopropyl sebacate, such as the product sold under the name of "Dub Dis" by Stearinerie Dubois, octanoates, decanoates or ricinoleates of alcohols or polyalcohols, such as propylene glycol dioctanoate; hydroxylated esters, such as isostearyl lactate or diisostearyl malate; and pentaerythritol esters; citrates or tartrates, such as di(linear C12-C13 alkyl) tartrates, such as those sold under the name Cosmacol ETI® by Enichem Augusta Industriale, and also di(linear C14-C15 alkyl) tartrates, such as those sold under the name Cosmacol ETL® by the same company; or acetates; (v) fatty alcohols that are liquid at room temperature, containing a branched and/or unsaturated carbon-based chain containing from 12 to 26 carbon atoms, for instance octyldodecanol, isostearyl alcohol, oleyl alcohol, 2-hexyldecanol, 2-butyloctanol or 2- undecylpentadecanol; (vi) higher fatty acids, such as oleic acid, linoleic acid, or linolenic acid; (vii) carbonates, such as dicaprylyl carbonate, such as the product sold under the name Cetiol CC(TM) by Cognis; (viii) fatty amides, such as isopropyl N-lauroyl sarcosinate, such as the product sold under the trade name Eldew SL 205(TM) from Ajinomoto; and (ix) essential oils selected from the group consisting of sunflower oil, sesame oil, peppermint oil, macadamia nut oil, tea tree oil, evening primrose oil, sage oil, rosemary oil, coriander oil, thyme oil, pimento berries oil, rose oil, anise oil, balsam oil, bergamot oil, rosewood oil, cedar oil, chamomile oil, sage oil, clary sage oil, clove oil, cypress oil, eucalyptus oil, fennel oil, sea fennel oil, frankincense oil, geranium oil, ginger oil, grapefruit oil, jasmine oil, juniper oil, lavender oil, lemon oil, lemongrass oil, lime oil, mandarin oil, marjoram oil, myrrh oil,
neroli oil, orange oil, patchouli oil, pepper oil, black pepper oil, petitgrain oil, pine oil, rose otto oil, rosemary oil, sandalwood oil, spearmint oil, spikenard oil, vetiver oil, wintergreen oil, and ylang ylang. [00126] Hydrocarbon-based oils may be glyceride triesters and in particular to caprylic/capric acid triglycerides, synthetic esters and in particular isononyl isononanoate, oleyl erucate, C12- C15 alkyl benzoate, 2-ethylphenyl benzoate and fatty alcohols, such as octyldodecanol. As volatile hydrocarbon-based oils, mention is made of hydrocarbon-based oils containing from 8 to 16 carbon atoms and in particular of branched C8-C16 alkanes, such as C8-C16 isoalkanes of petroleum origin (also known as isoparaffins), such as isododecane (also known as 2,2,4,4,6- pentamethylheptane), isodecane or isohexadecane, the oils sold under the Isopar or Permethyl trade names, branched C C8-C16 esters, and isohexyl neopentanoate. [00127] In some embodiments, the skin conditioning composition may comprise one or more oils such as from those described herein above, and from oils that may be selected from branched or linear, liquid alkane with carbon chain length of C11 to C20. In various embodiments, liquid alkanes may be selected from those with a carbon chain length of from C11 to C20. The liquid alkanes may be selected from those with a carbon chain length of from C11 to C20, or from C15 to C19, or one of C11, C12, C13, C14, C15, C16, C17, C18 to C19. In some embodiments, suitable liquid alkanes that may be used according to the disclosure include hydrocarbon-based oils containing from 8 to 16 carbon atoms, and especially branched C8-C16 alkanes such as C8-C16 isoalkanes. [00128] In some embodiments, the skin conditioning composition may comprise one or more oils selected from polar emollients selected from esters, triglycerides, ethers, carbonates, alcohols, oils, butters, fatty acids, and their combinations thereof. In various embodiments, the polar emollients may be selected from those with a molecular weight of 400 g/mol or less. More, generally, the polar emollient may have a molecular weight in the range from about 50 g/mol% to about 350 g/mol. [00129] In some embodiments, the skin conditioning composition may comprise polar emollients that include those derived from C12-C50 fatty acids, preferably C16-C22 saturated fatty acids, and monohydric alcohols. In some embodiments, such esters may be chosen from
isopropyl myristate, methyl palmitate, isopropyl laurate, isopropyl palmitate, ethylhexyl palmitate, ethylhexyl laurate, ethylhexyl oleate, ethylhexyl isononanoate, myristyl myristate, 2- ethylhexyl caprate/caprylate (or octyl caprate/caprylate), 2-ethylhexyl palmitate, isostearyl neopentanoate, isononyl isononanoate, hexyl laurate, esters of lactic acid and of fatty alcohols comprising 12 or 13 carbon atoms, dicaprylyl carbonate and their mixtures. [00130] The one or more oil, when present, alone or in combination as a blend of oils, may be present in the skin conditioning composition from about 0.0001% to about 20% or from about 0.001% to about 0.0010%, or from about 0.003% to about 0.004%, or from about 0.01% to about 0.1%, or from about 0.1% to about 10%, or from about 0.5% to about 20%, or from about 1% to about 10%, or from about 5% to about 10%, or from about 2% to about 7%, or from about 0.5% to about 2%, or from about 0.008% to about 0.01%, or from about 0.1% to about 0.2%, or from about 0.5% to about 2%, or from about or any suitable combination, sub- combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. In some embodiments, the skin conditioning composition includes more than one oil, each oil present in an amount as set forth herein above, wherein each different oil (such as, for example, plant oils and extracts with oils) may be present within one of the ranges selected from the ranges set forth herein above. [00131] Thus, each of the at least one oil or combination of oils, if present, is present by weight, based on the total weight of the skin conditioning composition, from about 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 to about 20 percent, including increments and ranges therein and there between. [00132] Surfactant [00133] In accordance with the disclosure, various non-limiting embodiments of the skin conditioning composition may optionally include at least one surfactant. And in accordance with the disclosure, various non-limiting embodiments of the skin conditioning composition that include an oil, for example, but not limited to, a Vitamin E component, such as tocopherol, may optionally include at least one surfactant. In some embodiments, the skin conditioning
composition comprises no oil. In some embodiments, the skin conditioning composition comprises no surfactant. In some embodiments, the skin conditioning composition comprises at least one oil, for example, tocopherol, with at least one surfactant. In some embodiments, the skin conditioning composition comprises at least one oil with more than one surfactant. In some embodiments, the skin conditioning composition comprises at least one oil without any surfactants, wherein the total amount of oil present does not inhibit forming the skin conditioning composition as a clear, single phase solution. [00134] The at least one surfactant may be an nonionic, cationic, anionic, or a zwitterionic surfactant. The at least one surfactant may be selected from the group consisting of polyoxyethylene sorbitan monolaureate, laureth-23, polyoxyethylated octyl phenol, 3-((3- cholamidopropyl) dimethylammonio)-1 propane sulfonate, sodium dilauramidoglutamide lysine, cholate, deoxycholate, sodium dodecylsulfate, TWEEN-80, and combinations thereof. The at least one surfactant may exclude esters. The at least one surfactant may be present in the skin conditioning composition in a range from about 1% to about 5%, based on the weight of the skin conditioning composition. [00135] In some particular embodiments the at least one surfactant, when present, comprises one or a combination of polyoxyethylene sorbitan monolaureate and laureth-23. [00136] In various embodiments, the at least one surfactant, when present, may be present from about 1% to about 5% by weight of the skin conditioning composition, and in some embodiments, from about 1% to about 2% , and in some embodiments, from about 3% to about 6%, and in some embodiments, from about 3% to about 4.5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. In some embodiments, laureth-23 may be present from about 1% to about 5% by weight of the skin conditioning composition, and in some embodiments, from about 3% to about 4.5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. In some embodiments, polyoxyethylene sorbitan monolaureate may be present from about 1% to about 5% by weight of the skin conditioning composition, and in some embodiments, from about 1% to about 2%, or any suitable combination, sub-combination,
range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. In some embodiments, the skin conditioning composition comprises more than one surfactant. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. [00137] Thus, in various embodiments, when present, each of the at least one surfactant may be present in a composition according to the disclosure from about 1, 2, 3, 4, to about 5 percent, by weight, including increments and ranges therein and there between. [00138] Polymeric Thickener [00139] In accordance with the disclosure, various non-limiting embodiments of the skin conditioning composition may optionally include one or more polymeric thickeners. In some embodiments, the one or more thickener may be selected from one or more of natural gums and synthetic polymers, for example, the thickener may be selected from the group consisting of starches (corn, rice, tapioca, potato), gums (xanthan carrageenan, gellan, sclerotium, tarabiotech fermentation). In some particular embodiments, the thickener may be selected from acrylates/C10-30 alkyl acrylate crosspolymer, carbomer, xanthan gum, hydroxypropyl guar, ceratonia siliqua (carob) gum, ammonium polyacryloyldimethyl taurate, ammonium acryloyldimethyltaurate/steareth-25 methacrylate crosspolymer, and polyacrylate crosspolymer-6. [00140] In some embodiments, the polymeric thickener may be one of carbomer, acrylates/C10-30 alkyl acrylate crosspolymer, polyacrylate crosspolymer-6, microcrystalline cellulose (and) cellulose gum, xanthan gum, sodium carboxymethyl starch, sclerotium gum (and) xanthan gum, xanthan gum (and) ceratonia siliqua (carob) gum (50/50), dehydroxanthan gum, hydroxypropyl starch phosphate, sclerotium gum (and) xanthan gum (75/25), sclerotium gum, xanthan gum (and) sclerotium gum (and) Lecithin (and) pullulan, or combinations thereof. [00141] In some embodiments the skin conditioning composition may comprise two or more polymeric thickeners. The amount of each of the at least one polymeric thickener, when present, may be present in the skin conditioning composition in a range of from about 0.01% to about 2%, or from about 0.01% to about 1.5%, or from about 0.3% to about 1.2%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the
weight of the skin conditioning composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. [00142] In some embodiments, the total amount of polymeric thickener in the skin conditioning composition, when present, is present from about 0.01% to about 5%, or from about 0.02% to about 2%, or from about 0.03% to about 1.5%, or from about 0.1% to about 0.2%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. [00143] Thus, one or more polymeric thickener, when present, is present by weight, based on the total weight of the skin conditioning composition, from about 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.5, 4.0, 4.5 to about 5.0 percent, including increments and ranges therein and there between. [00144] Preservatives [00145] In accordance with the disclosure, various non-limiting embodiments of the skin conditioning composition may optionally include one or more preservatives and/or antimicrobials. Any preservative commonly used in cosmetic formulations is an acceptable preservative for the skin conditioning compositions herein, such as phenoxyethanol, salicylic acid, members from the paraben family such as the methyl, ethyl, propyl, butyl or isobutyl parabens, 4-hydroxy benzoic acid, benzoic acid, sorbic acid, dehydroacetic acid, triclosan, benzyl alcohol, chlorophenesin, or for example. [00146] In some embodiments, the preservative may comprise one or more of preservatives selected from the group consisting of organic acids, parabens, formaldehyde donors, phenol derivatives, quaternary ammoniums, alcohols, isothiazolinones, and combinations thereof. Preservatives having antibacterial activity are optionally present in the skin conditioning compositions of the present invention. Examples of organic acid preservatives include, but are not limited to, sodium benzoate, potassium sorbate, benzoic acid and dehydroacetic acid, sorbic acid, and combinations thereof. A preferred organic acid preservative system includes a mixture of sodium benzoate and potassium sorbate. Examples of paraben preservatives
include, but are not limited to, alkyl para-hydroxybenzoates, wherein the alkyl radical has from 1, 2, 3, 4, 5 or 6 carbon atoms and for example, from 1 to 4 carbon atoms e.g., methyl para- hydroxybenzoate (methylparaben), ethyl para-hydroxybenzoate (ethylparaben), propyl para- hydroxybenzoate (propylparaben), butyl para-hydroxybenzoate (butylparaben) and isobutyl para-hydroxybenzoate (isobutylparaben). Examples of formaldehyde donor preservatives include, but are not limited to, 1,3-Dimethylol-5,5-dimethylhydantoin (DMDM hydantoin), imidazolidinyl urea, gluteraldehyde, and combinations thereof. Examples of quaternary ammonium preservatives include, but are not limited to, benzalkonium chloride, methene ammonium chloride, benzethonium chloride, and combinations thereof. Examples of alcohol preservatives include, but are not limited to, ethanol, benzyl alcohol, dichlorobenzyl alcohol, phenoxyethanol, and combinations thereof. Examples of isothiazolone preservatives include, but are not limited to, methylchloroisothiazolinone, methylisothiazolinone, and combinations thereof. [00147] Other suitable preservatives include, but are not limited to, chloroacetamide, triclosan and iodopropynyl butylcarbamate, pyridine derivatives (e.g., pyrithione and zinc pyrithione), chlorphenesin, phenyl mercuric salts, phenoxyethanol, and other known preservative systems. [00148] In some embodiments, the preservative includes one or more preservatives, the one or combination present at a concentration, by weight of about 0.001% to about 5%, or alternatively about 0.05% to about 2.5% or alternatively about 0.1% to about 2.0%, based upon weight of the skin conditioning composition. [00149] Thus, any one of or a combination of preservatives, when present, may be present, by weight, based on the total weight of the skin conditioning composition, is from about 0.001, 0.002, 0.003 ,0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03 ,0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, to about 5 weight percent, including increments and ranges therein and there between. [00150] Other Optional components [00151] In accordance with the disclosure, various non-limiting embodiments of the skin conditioning composition may optionally include one or more other additives or
actives(optional components), selected from, for example, actives such as acetyl trifluoromethylphenyl valylglycine; a humectant in addition to any glycol, for example caprylyl glycol, squalane, sugars, such as, glucose, xylitol, maltitol, sorbitol, sucrose pentaerythritol, inositol, pyrrolidone carboxylic acid, lactic acid, lithium chloride, acetamide MEA, , dicyanamide, hyaluronic acid, aloe vera, honey, and seaweed extract; preservative and anti-microbial components (such as those listed above), particularly, for example, salicylic acid, and phenoxyethanol; phenolic compounds, such as chalcones, flavones, flavanones, flavanols, flavonols, dihydroflavonols, isoflavonoids, neoflavonoids, catechins, anthocyanidins, tannins, lignans, aurones, stilbenoids, curcuminoids, alkylphenols, betacyanins, capsacinoids, hydroxybenzoketones, methoxyphenols, naphthoquinones, and phenolic terpenes, resveratrol, curcumin, pinoresinol, ferulic acid, hydroxytyrosol, cinnamic acid, caffeic acid, p-coumaric acid, baicalin (Scutellaria Baicalensis root extract), pine bark extract (Pinus Pinaster bark/bud extract), ellagic acid; and vitamins and vitamin derivatives, such as calcium pantothenate, tocopherol and ascorbic acid; fillers such as clays, talc, organic thickeners with for instance, anionic, cationic, nonionic, and amphoteric polymeric associative thickeners and combinations thereof; penetrants; sequestrants; fragrances; dispersants; film-forming agents; ceramides; opacifiers; organic or inorganic sunscreen actives and SPF boosters; and combinations thereof. [00152] Although the aforementioned optional components are given as an example, it will be appreciated that other optional components compatible with cosmetic applications known in the art may be used. [00153] In some embodiments, one or more optional components, alone or in combination, can be present in the skin conditioning composition according to the disclosure from about 0.05% to about 50% by weight, or from about 1% to about 30%, or from about 1.5% to about 20%, and from about 5% to about 15%, or from about 0.05% to about 2.5% by weight, or from about 0.1% to about 2%, or from about 0.25% to about 5%, and from about 0.5% to about 10%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. [00154] In some embodiments, one or more other components, such as preservatives, vitamins, and the like, alone or in combination, can be present in the skin conditioning
composition according to the disclosure from about 0.05 to about 50% by weight, or from about 0.05% to about 25% by weight, or from about 0.1 to about 10%, or from about 0.25% to about 5%, and from about 0.5 to about 3.5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the skin conditioning composition. [00155] In some exemplary embodiments, preservatives may include salicylic acid, and phenoxyethanol. [00156] Thus, one or a combination of optional components may be present, by weight, based on the total weight of the skin conditioning composition, or from about 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 to about 50 weight percent, including increments and ranges therein and there between. [00157] Complementary (Secondary) Compositions [00158] In various embodiments, complementary compositions may include any one or more of the ingredients described herein above, and in some examples specifically as described in the Optional Components. [00159] Desquamating Agents/Hydroxy Acids [00160] In accordance with the various embodiments of methods of use of the skin conditioning composition, the methods of use may include use of a complementary peel composition comprising at least one active ingredient selected from desquamating agents, for example, hydroxy acids. [00161] Alpha Hydroxy Acid [00162] In accordance with the various embodiments, the chemical peel component of the skin-enhancing treatment comprises at least one alpha hydroxy acid. [00163] Suitable alpha hydroxy acids include glycolic acid, lactic acid, tartaric acid, mandelic acid, citric acid, ester derivatives thereof and combinations thereof. Exemplary ester derivatives include ester compounds of lactic acid, such as methyl lactate, ethyl lactate, butyl lactate and, similarly, ester compounds of glycolic acid, tartaric acid, mandelic acid, citric acid.
One particularly suitable alpha hydroxy acid is lactic acid. Lactic acid, or 2-hydroxypropanoic acid, is provided to the chemical peel composition to provide enhanced exfoliation of the skin. In addition, lactic acid also boosts production of glycosaminoglycan (GAG) in the skin, improving the barrier function and moisturization of skin. [00164] And in some particular embodiments, the alpha hydroxy acid in the chemical peel component of the skin-enhancing treatment excludes at least one of lactic acid, glycolic acid, tartaric acid, mandelic acid, and citric acid. [00165] The chemical peel component of the skin-enhancing treatment includes a concentration of alpha hydroxy acid in a range from about 4% to about 15%, or from about 8% to about 14% or from about 9% to about 13%, or from about 10% to about 12%, or is about 10%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the chemical peel component of the skin-enhancing treatment. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. In accordance with some embodiments, the amount of alpha hydroxy acid present is not more than about 10%. [00166] Thus, any one of or a combination of alpha hydroxy acid is present, by weight, based on the total weight of the chemical peel component of the skin-enhancing treatment, from about 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, to about 15 weight percent, including increments and ranges therein and there between. [00167] Beta Hydroxy Acid [00168] In accordance with the various embodiments, the chemical peel component of the skin-enhancing treatment comprises at least one beta hydroxy acid. In some particular embodiments, the chemical peel component of the skin-enhancing treatment includes a beta hydroxy acid comprising salicylic acid. [00169] The term “beta-hydroxy acid” is understood to mean, according to the present invention, a carboxylic acid having a hydroxyl functional group and a carboxylic functional group separated by two carbon atoms. A beta hydroxy acid can be present in the chemical peel component of the skin-enhancing treatment in the form of the free acid and/or in the form of one of its associated salts (salts with an organic base or an alkali metal, in particular), especially
according to the final pH imposed on the chemical peel component of the skin-enhancing treatment. [00170] Suitable beta hydroxy acids include salicylic acid and derivatives thereof (including 5- n-octanoylsalicylic acid, salicylate, sodium salicylate, and willow extract), capryloyl salicylic acid, beta hydroxybutanoic acid, propionic acid, beta-hydroxy beata-methylbutyric acid, carnitine tropic acid, and trethocanic acid, and combinations of these. [00171] And in some particular embodiments, the beta hydroxy acid in the chemical peel component of the skin-enhancing treatment excludes at least one of salicylic acid and derivatives thereof (including 5-n-octanoylsalicylic acid, salicylate, sodium salicylate, and willow extract), capryloyl salicylic acid, beta hydroxybutanoic acid, propionic acid, beta-hydroxy beata- methylbutyric acid, carnitine tropic acid, and trethocanic acid. [00172] The chemical peel component of the skin-enhancing treatment includes a concentration of beta hydroxy acid in a range from about 0.1% up to and not more than about 2% of beta hydroxy acid, by weight, based on the total weight of the chemical peel component of the skin-enhancing treatment. In some embodiments, the chemical peel component of the skin-enhancing treatment includes up to and not more than about 2%, or about 1.9% of beta hydroxy acid. In some embodiments, the chemical peel component of the skin-enhancing treatment includes up to and not more than about 1% of beta hydroxy acid. In accordance with some embodiments, the amount of beta hydroxy acid present is not more than about 0.40% to about 0.50%. In some embodiments, the chemical peel component of the skin-enhancing treatment includes from about 0.1% to about 1% of beta hydroxy acid, or from about 0.2% to about 2.0%, or from about 0.1% to about 1.5%, or from about 0.2% to about 1.5%, or from about 0.3% to about 1.0%, or from about 0.35% to about 0.75%, or from about 0.4% to about 0.5%, or is about 0.45%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the chemical peel component of the skin-enhancing treatment. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. [00173] Thus, the at least one beta hydroxy acid is present in the chemical peel component of the skin-enhancing treatment from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.3,
1.4, 1.5, 1.6, 1.7, 1.8, 1.9, to about 2.0 weight percent, including increments and all ranges and subranges therein and there between. [00174] Phenylethyl Resorcinol [00175] In accordance with the various embodiments of methods of use of the skin conditioning composition, the methods of use may include use of a complementary composition comprising phenylethyl resorcinol. [00176] Phenylethyl resorcinol functions a tyrosinase inhibitor. The phenylethyl resorcinol, when utilized in the chemical peel component of the skin-enhancing treatment effectively whiten skin and reduce skin tone unevenness. Phenylethyl resorcinol has not shown adverse effects in basic toxicological tests, including acute oral toxicity, mutagenicity, skin irritation, skin sensitization, and phototoxicity. [00177] In accordance with the various embodiments, when present, the amount of phenylethyl resorcinol present in the chemical peel component of the skin-enhancing treatment is from about 0.2% to about 2.0%, or from about 0.2% to about 1.5%, or from about 0.4% to about 1.0%, or from about 0.6% to about 0.9%, or from about 0.7% to about 0.8%, or from about 0.2% to about 0.8%, is about 0.75%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the chemical peel component of the skin-enhancing treatment. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. In accordance with some embodiments, the amount of phenylethyl resorcinol present is not more than about 0.2% to about 0.8%. [00178] Thus, phenylethyl resorcinol, when present in the chemical peel component of the skin-enhancing treatment, is present, by weight, based on the total weight of the chemical peel component of the skin-enhancing treatment, from about 0.20, 0.30, 0.40, 0.50, 0.60, 0.70, 0.80, 0.90, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 to about 2.0 weight percent, including increments and ranges therein and there between. [00179] Articles of Manufacture [00180] In accordance with the various embodiments, the skin conditioning composition may be provided in a kit or other article of manufacture.
[00181] It will be appreciated that in the various embodiments of packaging, that the sub compositions that are packaged are maintained as separate until the skin conditioning composition and the at least one complementary composition is intended to be applied to keratinous tissue, at which time they may be separately applied or may be applied together, or may be combined and mixed prior to application. [00182] Generally, the skin conditioning composition is separate from the complementary composition until the skin conditioning composition is intended to be applied to keratinous tissue. Thus, one sub composition includes at least the hydrogen peroxide and any additional optional oxidizing agent, and one sub composition includes at least the alkaline booster. Variously, each of the sub compositions may include any one or more of the fatty compounds and any one or more of solvents, surfactants, polymers, actives, and other components. Further, any one or more of the fatty compounds and any one or more of solvents, actives and other components may be separately packaged from the other sub compositions, such that the article of manufacture may comprise more than two separate packages or package chambers. [00183] In one embodiment, the article of manufacture may be a packet with separate packages or chambers separated by a frangible seal between the chambers. In use, the seal is broken by the user to contact the separately packaged sub compositions and mix them prior to application onto the skin. In yet other embodiments, the article of manufacture may be a tube with dual chambers. Two parts are mixed when squeezing out from each chamber. In yet other embodiments, the article of manufacture may be a dual-chamber pump and the two parts can be mixed in after pumping out of the container. In some other embodiments, the packaging is a single tube with a seal between the two components that is broken to mix. In other embodiments, the packaging can be a single container holding a suspension of encapsulated material that is mixed/broken to disperse and mix. And in yet other embodiments, the packaging is otherwise sufficient to retain the skin conditioning composition separate from the complementary composition until the skin conditioning composition is intended to be applied to keratinous tissue. [00184] In some embodiments, the one or both of the first and second parts may be delivered by spray application, or other applicator selected from a pump, or brush.
[00185] In accordance with the various embodiments, a composition of the system for forming a continuous film mask is in a form including a suspension, lotion, cream, serum, essence, gel, stick, spray, ointment, paste, foam, mousse, cream, wipe, patch, strip, film- forming product. [00186] Examples: [00187] Example 1: Raw Materials [00188] The examples below according to the invention are given by way of illustration and without a limiting nature. The names are the chemical name or the INCI name. The amounts of active ingredients are given therein as % by weight based on raw material compositions comprising 100% of the listed ingredient, unless otherwise mentioned. Compositions and systems as described in the representative embodiments herein are selected from commercially available materials, including, as shown in the exemplified embodiments herein below, for example: Urea, glycine, serine, Latic acid, sodium lactate, triacetin, and triethyl citrate. [00189] Table 2: Raw Materials
[00190] Example 2: Inventive Compositions and Systems [00191] Five exemplary embodiments of the inventive composition are shown in Table 3. [00192] Table 3: Inventive Composition
[00193] Example 3: Effect of amino acid on pH [00194] In studies, the effect of amino acid (glycine) on pH was evaluated in compositions with 20% urea and with 40% urea. Stability of pH was not possible at either amount of urea when the amount of amino acid (glycine) was below 5%. The pH was stabilized in a range from about 5.5 to about 6.5 above 5% and up to about 9% amino acid (glycine). At and above 10% amino acid (glycine), the pH was stable in a range from about 5.5 to about 6.5 but the skin conditioning composition was unstable as evidenced by crystal formation. [00195] Example 4: Effect of buffer and amino acid (glycine or serine at 5%) on pH and stability [00196] In studies, the effect of buffer on pH and stability was evaluated in compositions with 20% urea and with 40% urea after a period of 4 weeks at 45 oC and at 4 oC. In all cases, in the presence of glycine at 5%, with and without buffer, the pH remained stable in a range from between 5.5 and 6.5, with overall better performance with buffer (a change of less than 10% over the time period). Similar results were obtained with serine, in a higher average range from about 7 to just above pH 7.5. In the absence of any amino acid, the pH increased from an average just above 7.5 at the beginning of the time period to greater than 8.5 (a change of more than 20% to almost 50% over the time period), with slightly better performance with buffer (a change more than 20% to about 35% over the time period). [00197] Example 5: Effect of 5% Proline vs 3% and 5% Glycine on pH at varying temperatures over time [00198] In studies, using a base composition according to INV#1, the amino acid was substituted to evaluate the effect of % Proline vs 3% and 5% Glycine on pH at varying temperatures over time in (with 40% urea). In all cases the starting pH was about 5.5. At 4 oC no meaningful effect was observed over 8 weeks, and at 55 oC a similar increase in pH was observed (increase to between 7 and 7.4) within one week. At temperatures of 25 oC, 37 oC and 45 oC, glycine was the most effective at stabilizing the pH as compared with proline, and 5% glycine stabilized the pH more effectively than the 3% glycine. At all temperatures, each of proline and 5% glycine maintained the pH at or below 7 through a period of 8 weeks. [00199] Example 6: Effect of triacetin
[00200] In studies, using a base composition according to INV#1 (40% urea, 5% glycine, 0.7% triacetin, buffer), triacetin was varied to evaluate its effect on pH and stability. Triacetin was varied at 0.1%, 0.4% and 0.7% and substituted with 1.2% and 2.4% triethyl citrate, and each sample was evaluated at 4 oC, 25 oC, 37 oC and 45 oC. In all examples, the results were comparable, with all samples showing a nominal change in pH at 4 oC , 25 oC and 37 oC, and all samples showing a change of about 10% to about 15% in pH at 45 oC. [00201] Example 7: Effect of glycols on pH and stability [00202] In studies, the effect of glycols on the pH and stability (from crystallization) of the composition of INV #1 with 40% urea and 5% amino acid (glycine) was varied in glycol content and glycol composition (glycerin and/or propylene glycol). Two samples of each formulation were tested, and the formulations included from 0% to 7% glycol (glycerin or propylene glycol), and glycerin:propylene glycol in ratios from 4:1 to 1:4. [00203] In the pH study, all samples were maintained for 8 weeks, at 25 oC and 45 oC. In all cases, the pH remained stable in a range from about 5.9 to about 6.9. [00204] In the stability study, only the formulations that contained only propylene glycol (at 3.5% and 7%) were free from crystal formation at both 4 oC at week 3, and after a freeze thaw cycle, as shown in Table 4. [00205] Table 4 s
**Freeze thaw
[00206] Example 6: Effect of Urea vs hydroxyethyl urea on peel efficacy using a hydroxy acid [00207] In studies, the effect of hydroxyethyl urea (HEU) was compared with urea in a base composition according to INV#1 (40% urea, 5% glycine, 0.7% triacetin, buffer) in which the amount and form of urea was varied. The test compositions included inventive compositions: INV #1 (40% urea), INV #1 (a) having 23% urea, INV #1 (b) having 23% HEU, and INV #1 (c) having 40% HEU. Studies were conducted with each of the tested compositions to evaluate effect of the compositions on the stratum corneum. [00208] In Vitro Stratum Corneum Comparison of Δ T using differential scanning calorimetry (DSC) is used to characterize the stability of a protein or other biomolecule directly in its native form. It does this by measuring the heat change associated with the molecule's thermal denaturation when heated at a constant rate. Compositions were evaluated on SC samples according to the following procedure. Stratum corneum samples were equilibrated at 75% overnight. Inventive and Comparative Compositions and control treatments applied on SC surface (0.1 g/sample) for 15 min in 75% relative humidity (RH). The SC surface was wiped clean and rinsed with DI water. Allow to dry in 75% RH overnight. The DSC profile was measured from 20 °C to 120 °C at 5 °C/min. [00209] As an initial step, each test composition was applied first to skin without rinsing, followed by application of a hydroxy-acid based peel composition in a moisturizer form. The results are shown in FIG 1, FIG 2 and FIG 3. [00210] The studies revealed that increased amounts of each of urea and hydroxyethyl urea resulted in increased desquamation as compared to use of the peel moisture alone, the desquamation evidenced by stratum corneum disorganization. Surprisingly, the compositions with urea outperformed those with HEU, and in particular, the 23% urea form performed as well as the 40% HEU form. [00211] While illustrative embodiments have been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.
[00212] The articles “a” and “an,” as used herein, mean one or more when applied to any feature in embodiments of the present invention described in the specification and claims. The use of “a” and “an” does not limit the meaning to a single feature unless such a limit is specifically stated. The article “the” preceding singular or plural nouns or noun phrases denotes a particular specified feature or particular specified features and may have a singular or plural connotation depending upon the context in which it is used. The adjective “any” means one, some, or all indiscriminately of whatever quantity. [00213] “At least one,” as used herein, means one or more and thus includes individual components as well as mixtures/combinations. [00214] The transitional terms “comprising”, “consisting essentially of” and “consisting of”, when used in the appended claims, in original and amended form, define the claim scope with respect to what unrecited additional claim elements or steps, if any, are excluded from the scope of the claim(s). The term “comprising” is intended to be inclusive or open-ended and does not exclude any additional, unrecited element, method, step or material. The term “consisting of” excludes any element, step or material other than those specified in the claim and, in the latter instance, impurities ordinarily associated with the specified material(s). The term “consisting essentially of” limits the scope of a claim to the specified elements, steps or material(s) and those that do not materially affect the basic and novel characteristic(s) of the claimed invention. All materials and methods described herein that embody the present invention can, in alternate embodiments, be more specifically defined by any of the transitional terms “comprising,” “consisting essentially of,” and “consisting of.” Further, it should be noted that for purposes of this disclosure, terminology such as "upper," "lower," "vertical," "horizontal," "inwardly," "outwardly," "inner," "outer," "front," "rear," etc., should be construed as descriptive and not limiting the scope of the claimed subject matter. Further, the use of "including," "comprising," or "having" and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless limited otherwise, the terms "connected," "coupled," and "mounted" and variations thereof herein are used broadly and encompass direct and indirect connections, couplings, and mountings. The term "about" means plus or minus 5% of the stated value.
[00215] Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and/or reaction conditions modified by the term “about,” are to be understood as being within 10% of the indicated number (e.g. “about 10%” means 9% – 11% and “about 2%” means 1.8% - 2.2%). [00216] All percentages and ratios are calculated by weight unless otherwise indicated. All percentages are calculated based on the total composition unless otherwise indicated. Generally, unless otherwise expressly stated herein, “weight” or “amount” as used herein with respect to the percent amount of an ingredient refers to the amount of the raw material comprising the ingredient, wherein the raw material may be described herein to comprise less than and up to 100% activity of the ingredient. Therefore, weight percent of an active in a composition is represented as the amount of raw material containing the active that is used, and may or may not reflect the final percentage of the active, wherein the final percentage of the active is dependent on the weight percent of active in the raw material. [00217] All ranges and amounts given herein are intended to include subranges and amounts using any disclosed point as an end point. Thus, a range of “1% to 10%, such as 2% to 8%, such as 3% to 5%,” is intended to encompass ranges of “1% to 8%,” “1% to 5%,” “2% to 10%,” and so on. [00218] Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the disclosure are approximations, unless otherwise indicated the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements. The example that follows serves to illustrate embodiments of the present disclosure without, however, being limiting in nature. [00219] While the invention has been described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiment
disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended claims.
Claims
What is claimed is: 1) A skin conditioning composition, comprising: a) urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; b) at least one amino acid; c) at least one of triacetin or triethyl citrate; d) optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of the skin conditioning composition is less than about 7. 2) The skin conditioning composition according to claim 1, wherein the composition is formulated as a leave-on product. 3) The skin conditioning composition according to claim 1, wherein the at least one amino acid is soluble in water at a pH from about 4 to about 6 and is selected from the group consisting of glycine, proline, serine, cysteine and combinations thereof. 4) The skin conditioning composition according to claim 1, wherein the urea or a derivative thereof, is present in an amount from greater than about 20% to about 40%, the at least one amino acid is present in an amount from about 5% to about 9%, and the at least one of triacetin or triethyl citrate is present in an amount from about 0.2% to about 2%, all amounts by weight, based on the weight of the composition. 5) The skin conditioning composition according to claim 1, wherein a) the at least one amino acid is selected from the group consisting of glycine, proline, serine, cysteine and combinations thereof and is present in an amount from about 5% to about 9%, by weight, based on the weight of the composition; b) the at least one of triacetin or triethyl citrate is present in an amount a range that includes about 0.2% to about 2%, by weight, based on the weight of the composition; c) the skin conditioning composition comprises a buffer system comprising one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof, and
d) the skin conditioning composition comprises at least one glycol selected from the group consisting of propylene glycol, glycerin, and combinations thereof, and wherein the skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 oC up to 45 oC and through freeze thaw cycles from -20 oC through 20 oC, characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7. 6) The skin conditioning composition according to claim 5, wherein the skin conditioning composition comprises propylene glycol and excludes glycerin. 7) A skin conditioning composition, comprising: a) urea present from greater than 20% to about 40%; b) at least one amino acid, the at least one amino acid comprising glycine present from about 5% to about 9%; c) at least one of triacetin or triethyl citrate, present from about 0.2% to about 2%; d) a buffer system having a pH in a range from about 4.0 to about 6.0, the buffer system comprising one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof; e) at least one pH adjusting reagent, comprising triethanolamine; and f) at least one glycol selected from the group consisting of propylene glycol, glycerin, and combinations thereof, wherein all amounts are by weight, based on the weight of the composition, and wherein the skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 oC up to 45 oC and through freeze thaw cycles from -20 oC through 20 oC, characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7. 8) A skin conditioning composition, comprising: a carrier system comprising a water phase,
the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH of the skin conditioning composition is less than about 7, wherein the cosmetic composition is one of a single phase solution comprising in the carrier system the water phase, or a multi- phase solution comprising in the carrier system the water phase and at least a second phase, or an emulsion comprising in the carrier system the water phase and at least a second phase comprising at least one oily phase. 9) The skin conditioning composition according to claim 8, wherein the carrier system further comprises one more additional ingredients, each present in the water phase or in a second phase. 10) The skin conditioning composition according to claim 9, wherein the one or more additional ingredients includes one or more of an additional ingredient selected from the group consisting of a skin active compound, a humectant in addition to any glycol, an oil, a surfactant, a thickener, a preservative, and combinations thereof, and wherein the skin conditioning composition is a product for keratinous tissue selected from a toner, a micellar water, a cream, a lotion, a cleanser, or a make-up remover. 11) A method for improving the efficacy of a skin care active, said method comprising: applying to a region skin, in any order: a first composition comprising a skin conditioning composition comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH is less than about 7; and a second composition comprising a complementary composition comprising one or more skin actives not present in the skin conditioning composition.
12) The method for improving the efficacy of a skin care active according to claim 11, wherein each of the first and second compositions is aqueous and is applied in liquid form, or the first composition is one of a water based toner or a mask, or wherein the first composition is a water based toner that is applied first followed by the second composition without prior removal of the first composition, or wherein the first composition is a water based mask that is applied first followed by the second composition, or wherein one or both of the first and second compositions is coupled to an application surface of an applicator, the application surface selected from the group consisting of a bristle surface of a brush, a roller surface of a rolling applicator, and a blade surface of a spatula, the method further comprising a step that includes rinsing to remove the first composition prior to application of the second composition. 13) A skin care system, comprising: a) A skin conditioning composition comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight, based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH is less than about 7; and b) a complementary composition comprising one or more skin actives not present in the skin conditioning composition wherein the skin conditioning composition is formulated as a leave-on product or a rinse of product and respecting the complementary composition, the composition is a leave on or rinse of skin peel composition comprising at least a hydroxy acid. 14) The skin care system according to claim 13, wherein, respecting the skin conditioning composition, a) the urea or a derivative thereof, is present in an amount from greater than about 20% to about 40%, by weight, based on the weight of the composition, and further
comprising at least one glycol selected from the group consisting of propylene glycol, glycerin, and combinations thereof; b) the at least one amino acid the at least one amnio acid is soluble in water at a pH from about 4 to about 6 and is selected from the group consisting of glycine, proline, serine, cysteine and combinations thereof and is present in an amount from about 5% to about 9%, by weight, based on the weight of the composition; c) the at least one of triacetin or triethyl citrate, is present in an amount a range that includes about 0.2% to about 2%, by weight, based on the weight of the composition; and d) wherein the skin conditioning composition comprises a buffer system comprising one or a combination of components selected from the group consisting of citric acid, sodium citrate, sodium lactate, lactic acid, and combinations thereof; e) wherein the pH of the skin conditioning composition is in a range from about 4.0 to about 6.0 and the skin conditioning composition optionally comprises at least one pH adjusting reagent comprising triethanolamine; and f) wherein the skin conditioning composition optionally comprises propylene glycol and excludes glycerin, wherein the skin conditioning composition demonstrates structural and pH stability for periods of up to about 8 weeks under temperature conditions that range from 4 oC up to 45 oC and through freeze thaw cycles from -20 oC through 20 oC, characterized as the absence of any or sustained visible crystallization and the stabilization of pH at or under a pH of about 7. 15) An article of manufacture for providing a skin system for improving the efficacy of a skin care active, the article of manufacture comprising: a) at least first and second separately contained compositions, i) the first composition comprising a skin conditioning composition comprising: a carrier system comprising a water phase, the water phase comprising urea or a derivative thereof, present in an amount from about 20% to about 40%, by weight,
based on the weight of the composition; at least one amino acid; at least one of triacetin or triethyl citrate; and, optionally, a buffer system having a pH in a range from about 4.0 to about 6.0, wherein the pH is less than about 7; and ii) the second composition comprising complementary composition comprising one or more skin actives not present in the skin conditioning composition. wherein the first and second compositions are one of (1) contained to be mixable prior to application to skin, (2) contained to be applied separately, in any order, (3) are each coupled to an application surface of an applicator, wherein the application surface is a surface of a mask configured to conform to a face of a wearer, and wherein the application surface is selected from the group consisting of a bristle surface of a brush, a roller surface of a rolling applicator, and a blade surface of a spatula, or (4) are each separately disposed in a first compartment of a sachet and the application surface is a surface of a second compartment of the sachet, and wherein the first compartment and the second compartment are fluidically separated by a breakable barrier.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163250577P | 2021-09-30 | 2021-09-30 | |
US202163250586P | 2021-09-30 | 2021-09-30 | |
US63/250,577 | 2021-09-30 | ||
US63/250,586 | 2021-09-30 | ||
FRFR2113556 | 2021-12-15 | ||
FR2113556A FR3130145B1 (en) | 2021-12-15 | 2021-12-15 | High Urea Skin Conditioning Cosmetic Composition |
FR2113553A FR3130147B1 (en) | 2021-12-15 | 2021-12-15 | SKIN REJUVENATION COMPOSITION WITH HIGH CONCENTRATION OF UREA TO STRENGTHEN SKIN CARE ACTIVE INGREDIENTS |
FRFR2113553 | 2021-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023052995A1 true WO2023052995A1 (en) | 2023-04-06 |
Family
ID=83688821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2022/059185 WO2023052995A1 (en) | 2021-09-30 | 2022-09-27 | Compositions with high urea content and methods for boosting actives |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023052995A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59134772A (en) * | 1983-01-20 | 1984-08-02 | Shiseido Co Ltd | Stabilization of urea |
FR2854070A1 (en) * | 2003-04-24 | 2004-10-29 | Oreal | Treatment of visible and/or tactile irregularities on human skin, for attenuating wrinkles, fine lines, pigmentation marks and/or acne scars, comprises applying topically to skin composition comprising, in medium, urea |
EP1743623A2 (en) * | 2005-07-13 | 2007-01-17 | L'oreal | Use of urea compounds for promoting desquamation |
US7999008B2 (en) | 2005-07-13 | 2011-08-16 | L'oreal | Urea compounds that promote desquamation |
CN112515992A (en) * | 2020-12-08 | 2021-03-19 | 上海家化联合股份有限公司 | Stable composition comprising triethyl citrate and glycine |
-
2022
- 2022-09-27 WO PCT/IB2022/059185 patent/WO2023052995A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59134772A (en) * | 1983-01-20 | 1984-08-02 | Shiseido Co Ltd | Stabilization of urea |
FR2854070A1 (en) * | 2003-04-24 | 2004-10-29 | Oreal | Treatment of visible and/or tactile irregularities on human skin, for attenuating wrinkles, fine lines, pigmentation marks and/or acne scars, comprises applying topically to skin composition comprising, in medium, urea |
EP1743623A2 (en) * | 2005-07-13 | 2007-01-17 | L'oreal | Use of urea compounds for promoting desquamation |
US7999008B2 (en) | 2005-07-13 | 2011-08-16 | L'oreal | Urea compounds that promote desquamation |
CN112515992A (en) * | 2020-12-08 | 2021-03-19 | 上海家化联合股份有限公司 | Stable composition comprising triethyl citrate and glycine |
Non-Patent Citations (1)
Title |
---|
DATABASE GNPD [online] MINTEL; 19 July 2021 (2021-07-19), ANONYMOUS: "Ultra K Anti-Roughness Cream", XP055941399, retrieved from https://www.gnpd.com/sinatra/recordpage/8870869/ Database accession no. 8870869 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2621922T3 (en) | Cosmetic composition comprising a compound of cucuric acid and a hydrophobic inulin | |
FR3117803A1 (en) | Composition comprising aqueous gelling agents, surfactant and ascorbic acid | |
FR3030255A1 (en) | COLORING COMPOSITION COMPRISING A PARA-PHENYLENEDIAMINE OXIDATION BASE, A POLYSACCHARIDE THICKENER IN A BODY-RICH MEDIUM | |
FR3117799A1 (en) | Composition comprising aqueous gelling agents, surfactant, oils, fillers and ascorbic acid | |
FR3030234A1 (en) | COLORING COMPOSITION COMPRISING A PARA-PHENYLENEDIAMINE OXIDATION BASE, NON-IONIC ACTIVE TENSIO IN A BODY-RICH MEDIUM | |
KR20220118489A (en) | A two-phase composition comprising an aqueous phase comprising at least one polyol in a content ranging from 5% to 30% by weight and an oil phase comprising a non-silicone oil | |
FR3058890A1 (en) | KERATINOUS FIBER STABILIZING AGENT COMPRISING 5-CYCLE HETEROCYLES | |
US20230095495A1 (en) | Skin conditioning composition with high concentration of urea to boost the skincare actives | |
JP6552280B2 (en) | Scalp cosmetic | |
WO2023052995A1 (en) | Compositions with high urea content and methods for boosting actives | |
US20230108443A1 (en) | Cosmetic skin conditioning composition with high urea content | |
AU2021310198B2 (en) | Branched amino acid surfactants for personal care and cosmetic products | |
KR102777610B1 (en) | Oil-in-water type cosmetic composition having excellent formulation stability | |
JP2023090305A (en) | Composition containing oil, water-soluble alcohol and ingredients derived from Nymphaeaceous plants | |
FR3054129A1 (en) | HAIR PROTECTIVE AGENTS AND OXIDATIVE HAIR COLORING METHOD WITH IMPROVED LIGHT EFFECT | |
WO2016102400A1 (en) | Composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound and a specific solvent | |
US11660261B2 (en) | High viscosity gel cleansing compositions | |
FR3108508A1 (en) | HAIR COSMETIC COMPOSITIONS CONTAINING A POLYOL, A SACCHARIDIC COMPOUND AND PECTIN AND METHODS OF USE | |
FR3105735A1 (en) | Composition comprising ascorbic acid | |
FR3058889A1 (en) | ALKALINE AGENTS FOR HAIR LIGHTENING COMPOSITIONS COMPRISING OXIDIZING AGENTS AND CARBOXYLIC ACID ESTERS AS KERATIN ARRAYS | |
US20220168210A1 (en) | High foaming cleansing composition | |
FR2926981A1 (en) | Composition, useful e.g. simultaneous styling and conditioning of hair, comprises vinylformamide/vinylformamine copolymers, different cationic polymers of vinylformamide/vinylformamine copolymers, and anionic and non-anionic surfactant | |
WO2022115744A2 (en) | High viscosity gel cleansing compositions | |
FR3131692A1 (en) | Composition comprising an oil, a water-soluble alcohol and a non-ionic guar gum | |
WO2016102402A1 (en) | Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a c2-c4 monoalcohol, and a glycol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22786504 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22786504 Country of ref document: EP Kind code of ref document: A1 |